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Abstract 
 
Inhaled particles reaching the alveolar walls have the potential to cross the blood gas barrier and 
enter the blood stream.  Pulmonary dosimetry, however, is not well understood.  Numerical and 
experimental studies shed some light on the mechanisms of particle transport, but realistic 
geometries have not been investigated.  In order to accurately predict particle deposition, the 
characteristics that affect deposition need to be understood.  This includes, but is not limited to, 
fluid flow, lung morphology, breathing conditions, and particle concentration.  Various 
geometries have been used for research, but very few are close representations to in vivo 
geometry.  Most studies have used simplified or idealized geometries based on published 
dimensions, but none replicate actual in vivo geometry; even fewer examine the differences that 
exist between healthy and diseased lung geometries. 
 
The following work analyzes and compares the flow fields that exist in replica healthy and 
emphysemic lungs by using realistic geometries and breathing conditions.  Actual human lung 
casts for in vivo healthy and emphysemic geometries were obtained, scanned, and used to 
reconstruct three dimensional replica models.  From these geometries, hollow compliant models 
were created and used to simulate breathing under healthy and diseased conditions.    It was 
shown that major geometric differences exist between the healthy and emphysemic models. 
Specifically, the emphysemic model alveoli appeared to merge into a single large alveolus with 
no potential regions of recirculation, as compared to the healthy model, which contained smaller, 
more distinct alveoli, and an overall model volume 11x smaller than the emphysemic model. 
 
Each experimental geometry was examined using stereoscopic particle image velocimetry 
(stereoPIV) techniques.  Realistic flow conditions were derived by the application of scaling 
theory to convert from the in vivo size to the large scale experimental set up.  Experimental 
techniques were validated by comparing to computational fluid dynamic (CFD) results when 
using a simplified three-dimensional (3D) bulb geometry.  Following validation, experimental 
flow fields were examined, on the large experimental scale, using velocity and streamline plots, 
for healthy and emphysemic geometries.  It was shown that reversible flow was present in both 
models; even in locations representing a high probability for recirculating or irreversible flow.   
ii 
 
Each of the experimental flow fields was then scaled to represent in vivo velocity predictions.   
The emphysemic model (run under normal emphysemic breathing conditions) had a flow rate 8x 
that of the healthy model with normal breathing.  The inlet velocity for the healthy normal 
breathing model, however, was 1.6x larger than the emphysemic.  These flow results are a 
function of both the model geometry and the applied realistic breathing conditions.  The 
distribution of in vivo velocity magnitude over the flow field was also different between the 
healthy and emphysemic models.  Specifically, the healthy model enters at higher velocities than 
the emphysemic, and then uniformly slows as the fluid moves towards the walls.  The 
emphysemic model yields a large region of fast flow near the inlet and slows at random locations 
as it approaches the walls.  It was reasoned that even though inhaled particles would likely travel 
further into the emphysemic model compared to the healthy, the distance to reach the wall would 
be much greater in emphysema as compared to healthy.  This would result in higher deposition 
efficiencies for healthy models as compared to emphysema, which is consistent with results 
found in the literature.  
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Chapter 1: Introduction and Background Information 
 
1.1 – Anatomy of the Lung 
The human respiratory tract is divided 
into three sections: the upper respiratory 
tract (consisting of the nasal passages 
and throat), the respiratory airways 
(made up of the larynx, trachea, bronchi, 
and bronchioles), and the lungs 
(consisting of respiratory bronchioles, 
alveolar ducts, alveolar sacs, and 
alveoli).  While most of the respiratory 
tract exists mostly to direct air to the 
lungs, the alveoli are the only part of the 
lung where oxygen and carbon dioxide 
exchange occurs (referred to as the 
pulmonary region).  Each human lung 
contains approximately 300 million 
alveoli with an average effective airway diameter of 200 to 300 microns (Angus and Thurlbec 
1972).  Figure 1.1 illustrates the anatomy of the most distal regions of the human lung; the 
bronchioles and acinus regions (occurring between generations 20 and 23).  Understanding the 
fluid mechanics occurring in the acinus region is of high importance because it is the region 
where gas exchange occurs. 
 
Emphysema is a chronic obstructive disease of the lung 
that occurs in the acinus region.  It is classified as a 
chronic obstructive pulmonary disease (COPD).  Over 
time, septa walls break down and air sacs lose their 
elasticity causing air to be trapped in the sacs.  This 
increases the overall volume of the alveolar sacs and A B 
Figure 1.2 - Illustrations of (A) healthy and 
(B) emphysemic alveoli (Metro Health 
System 2008). 
A B 
Figure 1.1 - (A) Subdivisions of the pulmonary airways and (B) 
the acinus region of the human lung (Netter 1979). 
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decreases the surface area through which gas exchange occurs.  It becomes increasingly difficult 
to expel carbon dioxide from the lungs causing a starvation for oxygen.  Figure 1.2 depicts the 
differences in geometry between healthy and emphysemic alveoli.  It is seen that the septa walls 
of the emphysemic sac have deteriorated causing individual alveoli to join into a single large 
alveoli.  Fifteen million Americans are currently affected by emphysema/COPD with 80-90% of 
the cases caused by smoking (Sciences 2009). 
 
Particle deposition in the pulmonary regions of the lung is not well understood; mainly because 
the current models do not reflect in vivo geometry.  In order to accurately predict deposition in 
various regions, the characteristics that affect deposition need to first be understood.  This 
includes fluid flow, lung morphology, breathing conditions, and particle concentrations or dose. 
 
1.2 – Alveolar Numerical and Experimental Models Found in Literature 
Many studies have examined the complex flow patterns in the pulmonary regions with 
increasingly more sophisticated geometries.  Tsuda et al. (1995) 
were some of the first researchers to study fluid mechanics in the 
alveolar region of the lung.  They developed a moving boundary 
circular channel geometry surrounded by a torus, an 
axisymmetric representation of an alveolus (Figure 1.3), and 
performed numerical simulations to predict the fluid flow in 
various regions of the lung.  The dimensions of the torus were 
varied to depict various lung generations.  The ratio of the depth, 
D, distance from the mouth opening to the bottom of the torus, to 
the mouth diameter, MD, distance of the mouth opening 
perpendicular to the depth, (D/MD), ranged from 0.50 to 0.87.  A 
terminating sac, however, was not studied.  This geometry was 
also used in the experimental research performed by Tippe and Tsuda (2000). 
 
Recently, more complex geometries have been created to better understand the complex in vivo 
flow patterns.  A comparison was completed on published work that dealt primarily with the 
Figure 1.3 - Axisymmetric alveolus 
used by Tsuda et al. (1995) and 
Tippe and Tsuda (2000).  QA = 
alveolar flow rate, QD = ductal flow 
rate, RA = alveolar radius, RD = 
ductal radius, γ = opening half angle. 
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lower generations, ideally terminating alveolar sacs and proximal generations.  The following 
studies were chosen based on similar scopes to the completed work in this document. 
 
Darquenne (2001) performed a computational fluid dynamic (CFD) simulation on a static wall 
geometry consisting of a symmetric channel surrounded by 
triangular shaped alveoli (Figure 1.4) with a D/MD ratio of 
1.03; representing generations 18 through 20. 
 
Karl et al. (2004) performed both numerical and 
experimental procedures on a stationary wall central channel 
geometry 
surrounded by 
numerous alveoli 
with a D/MD ratio 
ranging from 0.17 to 1.00 (Figure 1.5).  These values are 
representative of generations from the acinus region to an alveolated duct. 
 
Sznitman et al. (2007a; 2009) completed moving boundary numerical simulations on an 
alveolated duct with a single alveolus 
(Figure 1.6A), and on a truncated 
octahedron (14-hedron) geometry 
(Figure 1.6B).  The single alveolus 
model’s D/MD ratio ranged from 0.87 
to 0.90, representing the 15
th
 
generation to the 23
rd
 generation, but 
did not contain a terminal sac.  In the 
octahedron model, however, the D/MD 
ranged from 1.02 to 2.00 and 
represented generations labeled 3 through 8 (0 representing the transitional bronchioles); and 
included a terminating sac. 
 
Figure 1.5 - Central channel geometry used 
by Karl et al. (2004). 
A B 
Figure 1.6 - (A) Alveolated duct geometry used by Sznitman et al. 
(2007a) and (B) Truncated octahedron geometry used by Sznitman 
et al. (2009). 
Figure 1.4 - Symmetric channel 
geometry used by Darquenne (2001). 
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Similar to Karl et al. (2004), van Ertbruggen et al. 
(2008) performed both numerical and 
experimental studies on an alveolated duct.  Their 
model consisted of two alveolated ducts joined by 
a 145° bend and can be seen in Figure 1.7.  The 
stationary wall geometry had a D/MD of 1.50 
representing the 21
st
 generation. 
 
Oakes (2010; 2008) presented thesis work pertaining to experimental PIV research on moving 
boundary models of both healthy and diseased 
idealized geometry (Figure 1.8).  For the healthy 
model, a D/MD ratio of 0.66 was used, while 0.43 
was used for the emphysema model.  Both of the 
models represented terminating sacs, occurring at the 
23
rd
 generation. 
 
Similar in geometry to Oakes (2010; 2008), Kumar 
et al. (2009a) studied two honeycomb-like polygonal 
structures representing generations 18 to 22 and a 
terminating 23
rd
 generation (Figure 1.9).  Because of 
the complex geometry, the D/MD ratio was 
undetermined. 
 
A wide variety of experimental and 
numerical parameters have also be been 
studied, including constant input flow rates 
(van Ertbruggen et al. 2008; Darquenne 
2001; Karl et al. 2004), non-constant 
breathing curves (Tsuda et al. 1995; Tippe 
and Tsuda 2000), and sinusoidal breathing 
curves (Sznitman et al. 2007a; Sznitman et 
B Figure 1.7 - Alveolated duct model used by van 
Ertbruggen et al. (2008).  (A) Model dimensions, (B) 
experimental setup, and (C) numerical model. 
A B 
Figure 1.9 - Honeycomb geometry used by Kumar et al. 
(2008).  (A) Geometry representing generations 18 to 22 and 
(B) terminating alveolar sac representing the 23rd generation. 
A B 
D C 
Figure 1.8 - Idealized geometry used by Oakes 
(2008).  Healthy model (A) front and (B) top.  
Emphysemic model (C) front and (D) top. 
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al. 2009; Kumar et al. 2009a).  Oakes (2010; 2008), however, used a spirometry derived 
breathing curve; indicative of a healthy human breathing under normal conditions. 
 
1.3 – Summary of Alveolar Model Results from the Literature 
It was determined that the flow rate ratio (ratio of the alveolar flow rate to the ductal flow rate) is 
of great importance when studying alveolar flow mechanics.  Based on prior results, reversible 
flow is present when the flow rate ratio is greater than or equal to 0.05 (Tsuda et al. 1995; Tippe 
and Tsuda 2000; Kumar et al. 2009a).  Reversible flows represent fields that are identical on the 
inhalation and exhalation portions of the breathing curve.  If particles were introduced to a 
reversible flow, their path would be overlapping over a given breathing period (same path for 
inhalation and exhalation).  Sznitman et al. (2007a; 2009), however, reported reversible flow 
when the ratio was greater than 0.02.  Because the scope of the prior work varies from the 
current work, the flow rate ratio will be used to compare the results. 
 
Zones of recirculating eddies exist where flow separation occurs, causing a swirling effect in the 
fluid field.  Tsuda et al. (1995) and Tippe and Tsuda (2000) presented similar recirculation data 
with their joint geometry.  Both found recirculation regions where the flow rate ratio was small 
(ranging from 0.01 to 0.02 and from 0.02 to 0.06 for Tsuda et al. (1995) and Tippe and Tsuda 
(2000), respectively).  Both agree, however, that reversible flow is present above a flow rate ratio 
of 0.06.  Darquenne (2001) and Karl et al. (2004), however, found recirculation in all of their 
studied cases.  Sznitman et al. (Sznitman et al. 2007a; Sznitman et al. 2009) reported no 
recirculation in the terminal sac and the two proximal generations, but found recirculation in 
generations 19 and 20.  Oakes (2008) found reversible flow in both experimental models for all 
of her trials.  Similarly, Kumar et al. (2009a) found no recirculation in their terminating sac, but 
did, however, find recirculation in the generation immediately proximal. 
 
1.4 – Gaps in the Research 
Because in vivo geometry is complex and still not well understood, very few studies research the 
differences that exist between healthy and diseased lungs; including varying geometry or flow 
rates.  Recently, research was compared on the flow fields existing in idealized healthy and 
emphysematous lungs (Oakes 2008), while the experimental models were created from idealized 
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geometry dimensions (Weibel 1965; Haefelibleuer and Weibel 1988; Klingele and Staub 1970; 
Mercer et al. 1987; Kohlhaufl et al. 1997; Kohlhaufl et al. 2000).  Similar to previous studies, 
however, the geometry used in Oakes (2008) varies significantly from actual in vivo geometry. 
 
The complexity of the experimental and numerical geometries has evolved and more models are 
better representing in vivo geometry.  Actual in vivo geometry, however, has yet to be 
researched.  While most research has used breathing curves similar to realistic breathing 
conditions, few replicate the in vivo breathing curve.  It was shown that the input flow 
parameters have a significant impact on the fluid mechanics within the model.  Large flow rate 
ratios yield radial flows while low ratios show significant recirculation.  It is apparent that 
geometry representing a diseased alveolar sac has varying fluid mechanics, but radial flow is still 
present for a terminating sac. 
 
1.5 – Scope of the Thesis Work 
The goal of this research was to aid in the better understanding of the mechanisms that govern 
fluid motion and particle transport in the most distal regions of the lung and to compare the 
differences that exist between in vivo healthy and emphysematous models.  Specifically, the 
existence of recirculation regions in each model will be examined experimentally using 
stereoscopic particle image velocimetry (stereoPIV) techniques and comparisons between 
healthy and emphysemic geometries made.  The following aims were completed to achieve these 
research goals: 
 
Aim 1 – Create Compliant Hollow Models 
Develop two realistic experimental model prototypes (healthy and emphysemic) from in vivo 
human geometries and obtain compliant models of both geometries for use in stereoPIV 
experiments. 
 
Aim 2 – Develop PIV Setup Capable of 3D Flow Field Analyses 
In order to visualize 3D fluid flow in the experimental models, stereoscopic particle image 
velocimetry (StereoPIV) techniques were employed. 
 Develop an experimental setup to accommodate stereoPIV techniques. 
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 Create a LabVIEW program to monitor and control the expansion and contraction of the 
compliant experimental models based on desired input parameters. 
 Perform a fluid scaling analysis to ensure that the in vivo fluid fields are properly 
represented in the scaled experimental models. 
 Validate the stereoPIV setup by comparing the results of a full experimental analysis of 
simple 3D bulb geometry to the results of a CFD analysis. 
 
Aim 3 – Complete StereoPIV Analysis on Healthy and Emphysematous Models 
Using the validated setup in Aim 2, healthy and diseased models were analyzed and compared. 
 Compare geometry differences and how the flow fields are affected. 
 Analyze experimental and in vivo velocity fields for both models.  Compare the 
differences that exist between velocity magnitudes and distributions occurring in each model 
(for both experimental results and in vivo predictions). 
 Compare differences that affect particle transport in the flow fields for each model. 
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Chapter 2: Model Creation 
 
2.1 – Cast Human Lungs 
 
2.1.1 – Healthy Human 
Casting techniques of Phalen et al. (1973) were employed to cast human lungs from a fixed 
cadaver obtained through the Biological Sciences Department at RIT.  Healthy lungs were filled 
with CO2 to remove residual air then pumped with approximately 80 mL of saline to dissolve the 
CO2.  10 mL of 310 RTV was then injected into the lung using a syringe pump which forced the 
saline to diffuse through the lung membrane.  The casted lung was set overnight to cure and 
remained exposed to air for two weeks to dry out.  Once dried, the lung was soaked in a 4M 
NaOH solution for approximately two weeks to dissolve the tissue and expose the in vivo cast.  
The left lung of a healthy human (Figure 2.1A) was cast in the posterior and lateral basal sections 
of the lower lobe.  Sections of these casts were chosen for further analysis based on geometrical 
differences and the quality of the cast (Figure 2.1B and Figure 2.1C).  Specifically, portions 
having air bubbles or truncated regions due to improper flow of casting material were eliminated. 
 
Microscope pictures were taken of each of the pieces to determine which sections would be used 
for final reconstruction.  Healthy humans typically have alveolar mouth diameters of 
approximately 230 to 330 µm (Kohlhaufl et al. 2000) or 292 to 336 µm (Haefelibleuer and 
Weibel 1988) and represent defined bulb structures.  Our healthy human casts were within this 
range, and were measured between 243 and 378 microns.  Figure 2.2 represents microscope 
images of the two casts obtained from the healthy human.  An ideal cast contains no air bubbles 
with defined bulb geometry.  Based on the quality of the cast, the existence of uniform alveoli, 
and the presence of a terminating alveolar sac, the section in Figure 2.2B was chosen as the final 
healthy human cast model.  The circled section was scanned and used to create the final 
experimental healthy model.  Observation of the cast indicated that the terminal sac chosen for 
analysis was approximately 5 generations distal to the lower left lobar bronchi. 
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Piece 1 
Piece 2 
Upper 
left lobar 
bronchi 
Upper 
right 
lobar 
bronchi 
Middle 
right 
lobar 
bronchi 
Lower 
right 
lobar 
bronchi 
Lower 
left lobar 
bronchi 
A B C 
D 
Figure 2.1 - (A) Healthy human lung obtained from a fixed cadaver at RIT.  (B) Piece 1 and (C) piece 2 from 
the lateral basal lobe of the left lung.  (D) Schematic representing the casting locations in the healthy human left 
lung (Netter 1979). 
A B 
    
Figure 2.2 - Microscope images of (A) piece 1 and (B) piece 2 from the healthy human lung cast (red 
lines represent 1 mm).  Circled portion was scanned and reconstructed (see section 2.3.1). 
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2.1.2 – Emphysema Human 
A fixed human lung having characteristics of emphysema (Figure 2.3A) was obtained from the 
cadaver lab at RIT and cast using the same techniques used for the healthy human lung (Phalen 
et al. 1973).  After filling the lung with CO2, approximately 80 mL of saline was pumped in, 
followed by 60 mL of 310 RTV.  Unlike the healthy lung, two emphysemic lobes were cast.  
Figure 2.3B represents the emphysemic cast of the superior lower left lobe, while Figure 2.3C 
represents the cast of the anterior portion of the superior division of the upper left lobe. 
 
 
 
It was determined that pieces obtained from the cast in Figure 2.3C would be used for further 
analysis.  This was based on the geometrical differences that exist in the section and the overall 
quality of the cast.  Again, portions having air bubbles or truncated regions due to improper flow 
of casting material were eliminated.  It was also seen that Figure 2.3B did not contain defined 
bulb structures that were desired.  This portion represented more of a solid structure; which could 
Upper 
left lobar 
bronchi 
Upper 
right 
lobar 
bronchi 
Middle 
right 
lobar 
bronchi 
Lower 
right 
lobar 
bronchi 
Lower 
left lobar 
bronchi 
  
 
 
A B C 
D 
Figure 2.3 - (A) Human emphysemic lung obtained from the cadaver lab at RIT.  (B) Superior lobe cast and (C) 
Anterior lobe cast of the left lung.  (D) Schematic representing the locations of casting in the human 
emphysemic left lung (Netter 1979). 
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be an indication of over expanding and over casting, in addition to disease.  The chosen piece 
(circled region in Figure 2.3C) was then divided into smaller sections for further analysis.  
Microscope images of three separate pieces can be seen in Figure 2.4. 
 
 
 
Based on the quality of the cast, the existence of large alveoli, and the presence of a terminating 
sac, the section in Figure 2.4B was chosen as the final emphysemic human cast model and was 
scanned to create the final experimental emphysemic model (circled portion in Figure 2.4B).  
Literature cites emphysematous diameters ranging from 430 to 830 µm (Kohlhaufl et al. 2000) 
while our model’s average effective airway diameter measures 1556 microns; indicating that our 
model was obtained from a severely diseased lung or was over inflated during the casting 
process. 
 
2.2 – Obtain Micro-CT Scans of Cast 
Micro-CT images were obtained for each of the chosen lung casts to create 3D digital models.  A 
list of micro-CT vendors and their capabilities can be seen in Table 2.1.  Micro Photonics was 
chosen for their high resolution scanner and large image size.  Each of the models, healthy 
(Figure 2.2B) and emphysematous (Figure 2.4B), was sent to Micro Photonics for scanning and 
2D images were received three weeks after shipment.  
 
 
A B C 
 
 
 
 
 
 
Figure 2.4 - (A), (B), (C) Sections chosen for further analysis from the human emphysema lung cast.  (B) Section 
scanned and reconstructed (see section 2.3.1).  (Red lines represent 1 mm).  Circled portion represents the final 
experimental emphysemic human model section. 
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Table 2.1 - Chosen CT scan vendor (gray) compared to other considered venders. 
Vendor SUNY Upstate Micro Photonics Micro Photonics Scanco Medical 
Micro/Nano Micro 
High Resolution 
Micro 
High Resolution 
Nano 
High Resolution 
Micro 
Rates $258 $400-1000 $1,200 $350 
Resolution 
(microns) 
37 5   to   8 0.4 6 
Image Size 3072 x 2048 2k x 2k - 4k x 4k 1280 x 1024 
512 x 512 - 4096 x 
4096 
Image Format 16 bit RAW n/a n/a n/a 
Scan Dimensions 
8 cm (axial) x 5.4 
cm (transaxial) 
10mm - 78mm 
diameter (width) 
1mm maximum 
diameter 
36 mm max field of 
view 
5.4 cm (axial) x 8 
cm (transaxial) 
155mm diameter 
(height) 
5 mm height 140 mm max length 
 
 
2.3 – Create 3D Digital Model from 2D Slices 
 
2.3.1 – Reconstruct Whole Model 
The entire healthy human cast model 
(circled portion in Figure 2.2B) was 
reconstructed using the 2D images to 
determine a final model location.  3D 
Doctor (Able Software: Lexington, 
MA) was used to segment and 
reconstruct the models.  Figure 2.5 
shows a single 2D image of the 
healthy model with the entire model 
region selected.  This is the region that 
was segmented and reconstructed. 
Figure 2.5 - 3D Doctor ROI selected to include the entire model. 
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After selecting the whole model region, the images were auto-segmented.  This is a process that 
fills in the white areas of the image; indicating which boundaries to create.  An image threshold 
of 45 to 255 was chosen and image smoothing was selected.  After successfully segmenting all 
of the loaded images, a simple surface rendering was completed and exported as a *.obj file.  
VP-Sculpt (Visible Productions; Fort Collins, CO) was used to open and analyze the rendered 
3D model.  Figure 2.6A represents the original whole healthy human model that was 
reconstructed from the healthy cast.  From this model, a smaller section was chosen as the final 
model (Figure 2.6B). 
 
 
 
The same process was used for the emphysemic human model, but the entire model was unable 
to be reconstructed at once because of its size; too many facets and vertices.  Therefore, prior to 
reconstruction, a region of interest was determined by looking at the physical cast.  This smaller 
selected region was then able to be reconstructed because it contained fewer facets.  Figure 2.7A 
represents a partial reconstruction of the emphysemic human cast and the section chosen for the 
final emphysemic model (Figure 2.7B). 
Figure 2.6 - (A) Original whole healthy human reconstruction and (B) circled region selected for final model.  
(Both reconstructions are shown prior to 2D slice editing) 
A B 
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2.3.2 – Edit 2D Slices of Final Model Region 
Once the final region was chosen, the 2D images were edited for final processing.  As seen in 
Figure 2.8, holes and major voids were present in the 2D slices.  Images were edited in ImageJ 
(National Institutes of Health, USA) to remove the presence of holes in the final model.  Also, 
the edges of the images were cleaned up as to not interfere with the segmentation process.  
Editing is a very delicate and tedious process that is extremely time consuming, but is also 
necessary to obtain a usable final model.  Figure 2.8A represents a single 2D image that required 
edits.  The holes were filled and the wart like structures removed.  Figure 2.8B represents the 
same 2D slice after editing. 
 
 
A B 
Figure 2.7 - (A) Portion of the original emphysemic human reconstruction and (B) circled region selected for final 
model.  (Both reconstructions are shown prior to 2D slice editing) 
Holes 
Filled 
Warts 
Removed 
A B 
Figure 2.8 - (A) 2D slice showing where edits need to occur and (B) the final edited image. 
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Figure 2.9 illustrates the significance of editing the images prior to reconstructing.  Figure 2.9A 
displays a portion of a reconstruction using original images with no edits.  Large holes are visible 
and wart like structures can be seen on the surface.  Figure 2.9B shows the same reconstruction 
region using edited images.  It can be seen that the holes are filled and a majority of the warts 
removed.  The overall quality of the edited reconstruction has drastically increased and is 
necessary for obtaining a useable final model. 
 
 
The 2D editing process described above was applied to all of the images that make up the final 
model sections (Figure 2.6B and Figure 2.7B) to create a final reconstruction. 
 
2.3.3 – Process Surface of Final Model 
After the final models were reconstructed, VP-Sculpt was used to make final edits (fill holes and 
outer boundaries left by 3D doctor, remove improper facets/vertices, etc.) to the surface of the 
model and to decrease the number of model facets.  This allows the model to be opened in 
SolidWorks (Dassault Systèmes SolidWorks Corp.; Concord, MA) where a duct was added. 
 
After all of the holes and boundaries were filled, improper faces and vertices were deleted.  The 
process of deleting then filling in holes was repeated until holes/boundaries or improper 
faces/vertices no longer existed.  The model was then smoothed about 50 times using the default 
parameters to increase the quality of the surface. 
 
A B 
Figure 2.9 - (A) Portion of a healthy human reconstruction with circles showing where holes and 
wart structures exist and (B) the same reconstruction using edited 2D images. 
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Figure 2.10 displays the progression of obtaining a final edited 3D digital model from the 
original healthy human cast (shown from two different angles) while Figure 2.11 represents the 
emphysemic human final model progression.  The circled regions represent the portions of the 
models chosen for the final experimental models. 
 
 
 
 
2.4 – Create Inlet Duct 
An inlet duct was added to both of the final models using SolidWorks.  In order to open the 
model in SolidWorks, it was first decimated multiple times to decrease the number of facets 
Healthy Acinus Cast VP-Sculpt Digital 
Model 
Chosen Model Section Final Smoothed Model 
Figure 2.10 - Progression of obtaining a final 3D digital model from the original healthy cast (shown from two 
different angles). 
Figure 2.11 - Progression of obtaining a final 3D digital model from the original emphysemic cast. 
Emphysemic Acinus Cast 
VP-Sculpt 
Digital Model Chosen Model 
Section 
Final Smoothed Model 
17 
 
(small pieces that make up the surface of the model).  A total of four decimations were 
completed on the healthy model leaving 27,012 vertices and 54,032 facets (originally368,238 
vertices and 736,416 facets).  The emphysemic model was decreased to 23,497 vertices and 
46,982 facets (originally 1,589,498 vertices and 3,174,083 facets).  The healthy model was 
imported into SolidWorks as a surface body and an extrusion added based on the surrounding 
geometry of the model.  Figure 2.12 displays the progression of creating an inlet duct using 
SolidWorks for the healthy human model.  The circled sections represent the features that were 
added at each step. 
 
 
Figure 2.12 - Process of creating an inlet duct on the healthy human model using SolidWorks. 
 
The newly created duct and features were joined to the existing model and was completed using 
VP-Sculpt.  A tedious process of moving the duct into place on the healthy model was completed 
and is depicted in Figure 2.13. 
 
 
Figure 2.13 - Progression of translating duct onto healthy human model 
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A duct was also created for the 
emphysemic model, but further 
additions were first required.  
Because of the location of the 
final model section, portions of 
the model were cut from the rest 
of the geometry leaving flat 
surfaces where material exists 
in the whole model.  Therefore, 
the missing bulb structures were 
recreated manually (Figure 
2.14).  Figure 2.15 represents the final healthy and emphysemic models from three different 
views.  These models were scaled to in vivo dimensions then scaled to the proper experimental 
size as described in the following section. 
 
 
E D 
A B C 
F 
Figure 2.15 - Healthy human final model (A) front, (B) top, and (C) right views (inlet duct measures 113.6 
mm prior to scaling).  Emphysemic human final model (D) front, (E) top, and (F) right views (inlet duct 
measures 290.32 mm prior to scaling). 
Figure 2.14 - (Top) Original emphysemic model with the 
(Bottom) additions made to fill in voids. 
19 
 
2.5 – Scale Model 
 
2.5.1 – In Vivo Size 
The final models were first scaled to in vivo dimensions and then scaled to the desired 
experimental size (see Chapter 3).  Figure 2.16 represents the images of the in vivo models used 
for scaling.  The yellow lengths represent the known dimensions and the colored lines were then 
measured and used for the in vivo scaling.  When the final smoothed model sections were first 
brought into VP-Sculpt, the dimensions of the model were larger than the desired in vivo or 
experimental size (Figure 2.15).  Therefore, each colored length in Figure 2.16 was measured on 
the over-sized model and compared to the corresponding in vivo dimensions. 
 
Table 2.2 and Table 2.3 represent the measured in vivo and VP-Sculpt dimensions for the colored 
lines in Figure 2.16 for the healthy and emphysemic models, respectively. 
 
 
 
Comparing the VP-Sculpt dimensions to the desired in vivo size, an in vivo scaling factor of 
3.61E-3 was used for the healthy human model which yielded an in vivo volume of 1.3 mm
3
 
(0.013 mL) and an in vivo duct diameter of 0.41 mm.  The in vivo emphysemic model measured 
13.6 mm
3
 (0.136 mL) with a duct diameter of 0.90 mm (using a scaling factor of 3.06E-3). 
 
 
A B 
Figure 2.16 - Images of (A) healthy and (B) emphysemic models representing dimensions used for in vivo scaling.  
The yellow bar in (B) represents 1 mm. 
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Table 2.2 - Measured in vivo and VP-Sculpt dimensions for the healthy human model shown in Figure 2.16A. 
(An average scale factor of 3.61E-3 was used to scale from VP-Sculpt to in vivo size) 
 
In Vivo Dimension VP-Sculpt Dimension Scale Factor 
Yellow Scale 1 .0 mm N/A N/A 
Blue Line 0.43 mm 119.6 3.55E-03 
Red Line 0.40 mm 113.7 3.51E-03 
Green Line 0.25 mm 65.7 3.76E-03 
Duct Diameter 0.41 mm 113.6 3.60E-03 
 
Table 2.3 -Measured in vivo and VP-Sculpt dimensions for the emphysema human model shown in Figure 2.16B. 
(An average scale factor of 3.06E-3 was used to scale from VP-Sculpt to in vivo size) 
 
In Vivo Dimension VP-Sculpt Dimension Scale Factor 
Yellow Scale 1 .0 mm N/A N/A 
Blue Line 2.29 mm 759.67 3.01E-03 
Red Line 1.69 mm 552.04 3.06E-03 
Green Line 0.98 mm 317.85 3.08E-03 
Duct Diameter 0.90 mm 290.32 3.10E-03 
 
 
2.5.2 – Experimental Size 
Experimental parameters for both the healthy and emphysemic models were determined and can 
be seen in Chapter 3 (refer to Table 3.2 and Table 3.4, respectively).  Both experimental models 
have a duct diameter of 8 mm.  Therefore, the healthy model was scaled from in vivo size by a 
factor of 19.4 to yield an experimental model volume of 9013.5 mm
3
 (scaled from 0.41 mm to 
8.0 mm)   The emphysemic model, however, required a scaling factor of 8.9 to obtain a duct 
diameter of 8 mm from in vivo size; in vivo diameter of 0.9 mm corresponding to and 
emphysemic experimental model volume of 10488.6 mm
3
. 
 
2.6 – Create Compliant Models 
Physical prototypes of both of the experimental healthy (19.4x in vivo size) and emphysemic 
(8.9x in vivo size) models were obtained from Laser Reproductions (Gahanna, OH).  
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Specifically, each of the models was rapid prototyped using stereolithography techniques at a 
layer resolution of 0.006” and coated with a semi-bright nickel finish.  The finish is necessary to 
create a surface on the prototype that does not degas into the compliant dipping material.  This 
reduces the creation of bubbles in the compliant model and minimizes the amount of laser light 
refraction.  The healthy human prototype (Figure 2.17) measures 33 mm in length and 41 mm in 
width while the emphysemic prototype measures 31 mm long and 35 mm wide (Figure 2.18). 
 
 
 
 
Each of the physical prototype 
models were then dipped into a bath 
of melted Ultraflex (Douglas and 
Sturgess Inc.; Richmond, CA) and 
quickly removed.  To ensure 
uniform thickness throughout the 
compliant model, the models were 
A B C 
Figure 2.18 - Multiple views of the emphysemic human physical prototype model. 
A B C 
Figure 2.17 - Healthy human physical prototype model (A) top, (B) bottom, (C) left, and (D) right views. 
D 
Figure 2.19 - Compliant experimental model of the healthy human lung. 
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rotated once removed from the bath.  After completely cooled (waiting approximately ten 
minutes), the Ultraflex model was removed from the solid prototype.  Figure 2.19 and Figure 
2.20 represent images of the healthy human and emphysemic human compliant experimental 
models, respectively. 
 
When creating future prototypes, it is important to have a thick coating of nickel applied as to 
reduce the possibility of 
cracking.  Because the SLA 
material is not rated for the 
high melting temperatures it is 
exposed to, allowing the 
prototype to completely cool in 
between each dip is essential to 
maintaining a useable 
prototype model. 
Figure 2.20 - Compliant experimental model of the emphysemic human lung. 
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Chapter 3: Flow in the Experimental Model 
 
3.1. – Theory 
The incompressible, constant viscosity Navier-Stokes equations (White 2006) can be written in 
non-dimensional form as 
 
   
uP
U
dP
uu
Ud
t
ufd s 2
2
   (3.1)  
 
where Uuu /* , d* , sPPP /* , tft* , Ps is an arbitrary value chosen to balance the 
viscous term, ρ is density, u is velocity vector, t is time, P is pressure, µ is dynamic viscosity, f 
represents the breathing frequency (breaths/sec), d is duct diameter, and U is the time and 
spatially averaged inlet velocity.  The first dimensionless term in Equation 3.1 is related to the 
Womersley number, the ratio of oscillatory inertial to viscous forces (Loudon and Tordesillas 
1998; Womersley 1955), by 
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2
      (3.2)  
 
where ν is the kinematic viscosity of the fluid.  The second dimensionless term represents the 
time averaged Reynolds number (
Ud
Re ), the ratio of inertial forces to viscous forces, and 
can be written in terms of the experimental conditions as 
 
  d
fEV
i
4
Re       (3.3)  
 
where E is percent expansion and Vi is initial model volume.  Because the experimental models 
were scaled up from the in vivo size, the experimental parameters were derived as to match both 
the in vivo Re and Wo to the experimental Re and Wo , respectively, for both the healthy and 
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emphysemic models.  Based on fabrication techniques, however, an 8 mm model diameter was 
desired for both of the models.  Therefore, the other parameters affecting the Re and Wo were 
varied to properly match the in vivo conditions 
 
3.2 – Convergence of Small Wo and Re 
It is well understood that for small Re and Wo, non-dimensional velocity profiles are 
independent of Re and Wo, respectively.  To test the limits of this assumption, a computational 
fluid dynamic analysis was run on the expanding three dimensional bulb used for experimental 
validation seen in Figure 3.1A (Berg et al. 2010).  After verifying a grid independent solution, 
the non-dimensional profiles were obtained numerically for successively small Wo and Re using 
Fluent (Fluent, Inc.) at two locations in the model; in the center of the rigid duct at z = 0.55 mm 
and in the expanding bulb at z = 0.375 mm (Figure 3.1). 
 
 
Figure 3.1 - Velocity profiles for varying Wo occurring (A) in the expanding bulb at z = 0.375 mm and (B) 
in the rigid duct at z = 0.55 mm.  Velocity profiles for varying Re occurring (C) in the expanding bulb and 
(D) in the rigid duct. 
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Figure 3.2 shows that non-dimensional velocity profiles converge at about Wo = 0.2 and Re = 
0.7, which are both larger than the in vivo and experimental conditions in the present study.  
These results were used to insure that in vivo conditions were well represented experimentally, as 
explained in the following sections. 
 
 
 
3.3 – Healthy Human Parameters 
Table 3.1 represents the model and material properties for the healthy human model used for 
experimental analysis.  These values were concluded from the scaling analysis described in 
Chapter 2.  The experimental healthy model was scaled from the in vivo size by a factor of 19.4 
to obtain a duct diameter of 8 mm. 
 
Table 3.1 - Model and material properties for the healthy human model. 
Symbol Property 
In Vivo 
(Air at 20°C) 
Experimental 
(Glycerin at 20°C) 
d 
Acinus Inner Duct Diameter 
(mm) 
0.41 8.00 
Vi 
Mean Acinus Volume 
(mm
3
) 
1.25 9013.46 
ν 
Kinematic Viscosity 
(mm
2
/sec) 
17.10 909.80 
 
Figure 3.2 - Convergence plots for (A) Womersley and (B) Reynolds numbers showing that velocity profiles 
converge prior to reaching the maximum experimental Wo = 0.07 and before the maximum experimental Re = 0.24.  
NL refers to the non-dimensional locations in Figure 3.1. 
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In vivo breathing conditions for a healthy human breathing under normal conditions were 
determined based on information cited by Robinson et al. (2007).  Using an average functional 
residual capacity (FRC) of 3050 L and an average tidal volume (TV) of 483 mL, the calculated 
in vivo expansion (TV / FRC) is 16% with an average breathing frequency of 15.71 breaths/min.  
Using the properties in Table 3.1, the in vivo Re is 0.009 with a Wo of 0.03.  To simulate heavy 
breathing for a healthy human, however, Re and Wo were calculated using 60% expansion and 
found to be 0.04 and 0.03, respectively (Table 3.2).  Because both Re and Wo are small and less 
than the converged values of 0.7 and 0.2, respectively (section 3.2), this indicates that the flow 
fields in the alveoli region are unchanged for normal versus heaving breathing conditions in a 
healthy human. 
 
In order to match the experimental parameters with the in vivo conditions used in this work, the 
Wo was first matched because it is only a function of the breathing frequency; assuming the 
diameter is fixed at 8 mm (Equation 3.2).  For an in vivo Wo of 0.03, an experimental breathing 
frequency of 2.23 breaths/min was required (a period of 26.9 seconds).  Using this required 
frequency, an experimental expansion of 16% would then match the in vivo Re (Equation 3.3).  
The calculated in vivo and experimental flow parameters are shown in Table 3.2. 
 
Table 3.2 - Healthy human in vivo and experimental fluid parameters required to match Re and Wo. 
The grey values represent the chosen parameters used in this work. 
 
 
Breathing 
Frequency 
(breaths/min) 
Period 
(sec) 
Womersley 
Expansion 
(%) 
Reynolds 
In Vivo 
Air at 20° C 
Normal Breathing 15.7 3.8 0.03 16 0.009 
Heavy Breathing 15.7 3.8 0.03 60 0.035 
Experimental 
Glycerin at 20° C 
Matched Normal 2.2 26.9 0.03 16 0.009 
Matched Heavy 2.2 26.9 0.03 60 0.035 
Used in This Work 15.0 4.0 0.07 35 0.138 
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It is seen that the experimental period required to precisely match in vivo conditions is extremely 
large (26.9 seconds for a single breath to be completed).  This is not an ideal condition because 
the particle displacements between sequential images would be difficult to detect.  Also, because 
the motion of the pump would have to be extremely slow to produce a 26.9 second breathing 
period, we did not want to introduce residual particle motion into the system between sequential 
frames.  Therefore, a more realistic breathing period for experiments is 4 seconds. 
 
If a 4 second period was used rather than 26.9 seconds, the corresponding Wo is calculated to be 
0.07 with a Re of 0.14 (using an expansion of 35%), which is still small and less than the 
converged values of 0.2 and 0.7, respectively.  It is clear from the velocity profile plots (Figure 
3.1) that the in vivo conditions for both Re and Wo would be met for all proposed experimental 
healthy cases because the non-dimensional velocity profiles are identical for Womersley 
numbers of 0.03 and 0.07, and for Reynolds numbers of 0.02 and 0.20 (within the range of 
proposed experimental conditions).  Therefore, the presence of heavy breathing conditions has 
little effect on the flow field. 
 
The grey values in Table 3.2 represent the final experimental Re and Wo using a breathing 
period of 4 seconds as compared to the in vivo Re and Wo.  A 35% expansion was desired for the 
healthy model because the corresponding average input flow rate of 1.9 mL/sec coupled with the 
chosen pulse frequency of the laser (12.5 Hz) yields the appropriate particle displacement for 
collected image pairs. 
 
3.3 – Emphysemic Human Parameters 
Using the desired experimental duct diameter of 8 mm for the emphysemic model, a scaling 
factor of 8.9 was applied to the in vivo model (see Chapter 2).  The model and material properties 
for the in vivo and experimental emphysemic models are shown in Table 3.3 
 
In order to apply the same flow conditions to both the emphysemic and healthy models, the Re 
and Wo between each model were matched (Re = 0.14 and Wo = 0.07).  In order to achieve 
these values, an experimental expansion of 30% was required for the emphysemic model with a 
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breathing period of 4 seconds (the difference in experimental percent expansion is due to the 11x 
difference in initial volumes between the healthy and emphysemic models).   
 
Table 3.3 - Model and material properties for the emphysemic human model. 
Symbol Property 
In Vivo 
(Air at 20°C) 
Experimental 
(Glycerin at 20°C) 
d 
Acinus Inner Duct Diameter 
(mm) 
0.90 8.00 
Vi 
Mean Acinus Volume 
(mm
3
) 
14.39 10488.60 
ν 
Kinematic Viscosity 
(mm
2
/sec) 
17.10 909.80 
 
Table 3.4 - Emphysemic human in vivo and experimental fluid parameters required to match Re and Wo. 
The grey values represent the chosen parameters used in this work. 
 
 
Breathing 
Frequency 
(breaths/min) 
Period 
(sec) 
Womersley 
Expansion 
(%) 
Reynolds 
In Vivo 
Air at 20° C 
Normal Breathing 16.0 3.7 0.03 11 0.04 
Experimental 
Glycerin at 20° C 
Matched Normal 2.3 26.4 0.03 50 0.04 
Used in This Work 15.0 4.0 0.07 30 0.14 
 
The chosen experimental parameters for the emphysemic model are shown in grey in Table 3.4.  
Similar to the healthy model, an inlet flow rate of 1.94 mL/sec was applied to the emphysemic 
model.  It is seen that the chosen experimental parameters (Re = 0.14 and Wo = 0.07) are below 
the converged values of Re = 0.7 and Wo = 0.2 (see section 3.2).  Therefore, the presence of 
emphysemic conditions plays little to no role in alveolar flow.  This allowed us to focus solely on 
the differences in flow fields that exist between the healthy and emphysemic models due to 
geometry effects rather than input Re or Wo (for all values of Re ≤  0.7 and Wo ≤  0.2). 
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Chapter 4: Experimental Methods 
 
4.1 – StereoPIV Theory 
PIV is an optical measurement technique used to non-invasively obtain instantaneous velocity 
fields in fluid flows.  The fluid is seeded with small reflective tracer particles whose motion is 
tracked between images.  Stereoscopic PIV is based on the same fundamental principles as 
human eye-sight.  As with 2D measurements, stereoPIV measures displacements rather than 
actual velocities (with the cameras playing the roles of the eyes).  The most accurate 
determination of the out-of-plane displacement is accomplished when there is 90° between the 
two cameras.  The first camera would be able to capture the x and y components of velocity, 
while the second camera would capture the y and z components.  In the cases of restricted optical 
access, however, smaller angles can be used at the cost of a somewhat reduced accuracy.  For 
each vector, three true displacements (dX, dY, and dZ) are extracted from a pair of 2-
dimensional displacements (dx, dy) as seen from the left and right cameras, respectively.  Figure 
4.1 illustrates the fundamentals of the stereoPIV process.  The blue arrow, for example, would 
represent a single particle displacement through the light sheet.  The 2D particle displacement 
seen from left camera is shown as the red arrow, while the 2D particle displacement seen from 
the right camera is represented as the black arrow. 
 
 
  
X direction 
Z
 d
ir
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ti
o
n
 
Figure 4.1 - Fundamentals of stereoPIV (Dynamics 2010).  The x and z directions are 
depicted as right and up, respectively, while the y direction is out of the plane. 
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Due to perspective distortion 
occurring from the angle of the 
cameras with respect to the light 
sheet, each camera covers a 
trapezoidal region of the light sheet.  
Even with careful alignment of the 
two cameras, their respective fields of 
view only partly overlap each other.  
Within the region of overlap, 
interrogation points are chosen in a 
rectangular grid to match the spatial 
resolution of the cameras (Figure 4.2). 
 
The actual stereoscopic 
measurements begin with 
conventional 2D PIV processing of 
simultaneous recordings from left 
and right cameras, respectively. 
This produces two 2-dimensional 
vector maps representing the 
instantaneous flow field as seen 
from the left and right cameras, respectively (Figure 4.3). 
 
The acquired images are grey scale images with variations of light intensities representing the 
presence of fluorescent particles.  Each image set (two sequential image pairs) is separated by a 
known deltaT, the separation between laser pulses, and broken into small interrogation regions 
for cross correlation.  Figure 4.4 represents a typical interrogation region used for image 
processing (representing 32x32 pixel squares).  The group of particles that exists in each 
interrogation region represents a fairly unique ‘fingerprint’ that is tracked between both frames 
in the image set.  Once a unique pattern is found for a particular region, the mask is scanned 
through the defined search area in the second frame and a correlation value is calculated at each 
Figure 4.2 - Overlap area with interrogation region resulting from each 
cameras field of view (Dynamics 2010). 
Left Camera 2D Vector Map Right Camera 2D Vector Map 
Figure 4.3 - Processed 2D vector maps from each camera 
(Dynamics 2010). 
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position.  The value of the correlation function will be 
maximized when the ‘fingerprint’ is identified in the mask 
in the second frame.  Ideally, a single, distinct, round peak 
will exist in the correlation map.  Once identified, the x 
and y displacements of the particles are determined by the 
offset of the interrogation regions.  Finally, since the 
deltaT between laser pulses is known, the group velocity 
for a particular region is measured as the displacement 
divided by the deltaT, and a single vector is assigned for 
each interrogation region (Figure 4.5).  The process is completed for every interrogation region 
until all vectors are calculated (either real or interpolated).  Figure 4.6 illustrates a different 
perspective on the calculation of a velocity vector for a particular interrogation region. 
 
 
 
 
A B C 
Figure 4.5 - (A) Identify particle mask, (B) determine position change, and (C) 
calculate vector based on known displacement / known deltaT (TSI 2009). 
Figure 4.6 - Image processing theory representing a single correlation peak 
(LaVision 2009). 
Figure 4.4 - Typical interrogation region 
used for image processing. 
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Using the known parameters from the perspective 
calibration (distance from the object to the image, 
lens focal length, and camera angle), the points in 
the interrogation grid (overlap area occurring in 
Figure 4.2) are mapped from the light sheet plane 
onto the left and right image planes (camera sensor) 
respectively.  The 2D vector maps are re-sampled 
in the new interrogation regions to estimate 2D 
vectors at each point based on the nearest neighbours.  The resulting 3D vector map is then 
calculated and depicted in Figure 4.7. 
 
4.2 – Experimental StereoPIV Setup 
 
4.2.1 – Cameras and Optics 
The experimental setup developed in our lab for stereoPIV analysis is shown in Figure 4.8. 
 
 
 
Images were captured using two IDT Motion Pro X-3 Plus high-speed digital cameras, each 
equipped with a Tamron macro lens with a focal length of 90 mm, f-number of 2.8, and an image 
macro magnification ratio of 1:1.  Ideally, Scheimpflug mounts are used to focus on planar fields 
Figure 4.8 - Experimental stereoPIV setup developed in our lab. 
 
 
Figure 4.7 - Resulting 3D vector map 
(Dynamics 2010). 
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at oblique viewing angles.  Because they were not used in this experiment, the camera angles 
were minimized to allow the entire image to be in focus across the laser sheet.  Therefore, each 
camera was angled 15° from the perpendicular to the light sheet and was 7” from the center stand 
(30° between cameras as opposed to the ideal angle of 90° as described above).  The distance 
from the camera lens to the experimental model was chosen as to allow the entire experimental 
model to fit into the field of view of each camera, resulting in a spatial resolution of 64.23 µm 
per pixel occurring at the center of the experimental setup and varying as the light sheet location 
changes.  The fluid was illuminated with a New Wave Research Solo II pulsed 532 nm laser and 
8 µm red fluorescent polymer microspheres (Duke Scientific Corp.; Palo Alto, CA) were used as 
tracer particles in 99% glycerin carrier fluid (emitting at 612 nm).  A mirror, positioned on a 
rotation stage, was used to direct the beam from the laser to the optics.  A planar laser sheet was 
created by passing the collimated laser beam through a cylindrical lens, focal length of 25.4mm, 
and a spherical lens of focal length 150 mm.  The cameras were focused on regions of the 
experimental models in which the laser sheets waist (focal point of the beam) occurred, 
measuring approximately 1 mm thick and occurring in the center of the model.  The cameras and 
laser were synchronized using a TSI Laser Pulse Synchronizer and triggered with the start of 
each experiment. 
 
4.2.2 – Testing Fixture and Components 
The experimental testing rig (shown in Figure 4.8) was developed to contain the experimental 
models and to simulate the input breathing parameters to achieve the proper in vivo flow 
conditions.  Each compliant model was housed in a glycerin (refractive index of 1.47 ± 2.0E-3) 
chamber and filled with a glycerin / particle mix of approximately 0.007 grams of particles per 
150 mL of glycerin to achieve the appropriate mixture required to minimize PIV processing error 
(Soria 2000).  A computer controlled syringe pump drew a negative pressure on the chamber 
fluid, expanding the model and drawing glycerin from the inlet tube into the compliant model.  
Total model volume changes were verified with pressure sensors placed at the model inlet 
(MPXV5010GP, Freescale Semiconductor, Inc.) and at the base of the chamber (PX2300-10DI, 
Omega Engineering, Inc.).  The syringe pump (NE-500, New Era Pump Systems, Inc.) was fitted 
with a stepper motor and controlled by a motion controller (MBC25081TB, Anaheim 
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Automation), programmed using LabVIEW and a DAQ device (PCI-6025E DAQ, National 
Instruments Corp.). 
 
4.2.3 – LabVIEW Code 
A LabVIEW code was generated to accurately control the motion of the experimental models 
based on the in vivo flow conditions.  Once the experimental parameters were chosen (Chapter 
3), the Re and Wo were matched by varying the input controls (initial model volume, percent 
expansion, and breathing period).  Figure 4.9 represents the LabVIEW block diagram used to 
expand and contract the experimental models. 
 
 
 
Based on the initial volume and percent expansion of each model, the total volume change was 
calculated and converted to a linear distance based on the area of the syringe used (140 mL 
syringe with a cross sectional area of 1.7203 in
2
).  The average linear distance moved per step of 
the motor was 6.2E-5 in.  Therefore, the total number of steps and step frequency (number of 
steps / inhalation time) was calculated and applied to the stepper motor.  Each model required a 
flow rate of 1.94 mL/sec for a 4 second period (see Chapter 3) corresponding to a 3.15 mL 
volume change over the inhalation time (1.62 seconds).  Therefore, for each model, a total of 
1,802 clicks were required at a frequency of 1,112 clicks / second.  At the start of the motion of 
the pump, a 5V trigger was sent to the pulse synchronizer to begin image capture.  Finally, data 
Figure 4.9 - LabVIEW block diagram used to expand and contract the experimental models. 
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from the pressure sensor located at the inlet to the model was sampled and displayed to verify the 
correct volume change during each experiment. 
 
4.3 – Image Capture 
TSI’s Insight 3G (TSI Inc., Shoreview, MN, USA) was used to capture images for each 
experiment.  Figure 4.10 
represents the capture settings 
used for each of the 
experimental models.  A 
single pulse / frame for each 
camera was used with a 
frequency of 12.5 Hz (deltaT 
of 0.08 seconds between 
sequential laser pulses and 
images).  Because a period of 4 seconds was chosen for each model, a total of 50 images were 
required for each data set, but a total of 75 images were actually collected to account for any 
residual fluid motion.  Because two cameras were used, 75 images were collected for the left 
camera and 75 collected for the right (a total of 150).  For each laser sheet location, a total of 
three data sets were collected to illustrate the repeatability of the experimental results (refer to 
section 5.2.5 for variability analysis). 
 
4.4 – Healthy Human Analysis Settings 
A total of fourteen laser locations were selected for the healthy human model.  The laser sheet 
was initially positioned just inside the model then moved in 3.2 mm (1/8”) intervals, collecting 
data at every new sheet location.  At every position, the distance from the object to the image 
was measured (distance from the light sheet to the CCD array in the camera).  This information 
was necessary to create an accurate perspective calibration file needed for image processing.  In 
order to achieve the correct in vivo flow conditions (refer to Chapter 3), the input parameters 
shown in Figure 4.11 were applied at each laser plane location (breathing period of 4 seconds 
and model expansion of 35%). 
Figure 4.10 - Capture settings for stereoPIV experiments. 
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Table 4.1 represents the measurements collected for each laser sheet location where data was 
analyzed, including the two regions where recirculation would be most likely to occur. 
 
Table 4.1 - Measurements obtained for each laser sheet location analyzed (RR = recirculation region). 
 
Mirror Location (mm) Distance Object to Image (mm) 
2ndLocation 43.7 669.9 
4thLocation 50.0 663.6 
6thLocation 
(1st RR) 
56.4 657.2 
8thLocation 
(2nd RR) 
62.7 650.9 
10thLocation 69.1 644.5 
12thLocation 75.4 638.2 
 
Figure 4.11 - LabVIEW output for a healthy human experiment displaying the input parameters 
required to match in vivo conditions (4 second period and 35% expansion resulting in an inhale 
flow rate of 1.94 mL/sec). 
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4.4.1 – Creating Calibration Files 
Insight 3G was used to process the raw images collected from each laser sheet location.  First, a 
perspective calibration file was created for each location.  This allows the program to account for 
the magnification changes that occur across the field of view of the camera with respect to the 
center of the light sheet.  Figure 4.12 represents the left and right calibration files for the second 
location in the healthy human model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.2 – Stereo AutoMapping 
Prior to processing the raw images, it was important to translate the images to make sure they 
were on top of each other.  
Figure 4.14 represents an image 
pair prior to translating with a 
blue grid overlaid representing 
50 pixels per square.  It can be 
seen that Figure 4.14B needs to 
be translated approximately 100 
pixels to the left and 10 pixels 
down to align with Figure 
4.14A.  This translation was 
Figure 4.13 - Pixel to length conversion 
for the 2nd location created from the 
information in Figure 4.12. 
Figure 4.14 - Images prior to translating (grid represents 50 pixels). 
A B 
A B 
Figure 4.12 - (A) Left and (B) right perspective 
calibration files for the 2nd location in the healthy 
healthy human model. 
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completed using ImageJ and was necessary for all image sets analyzed.  A stereo AutoMapping 
procedure was then completed on all selected laser sheet locations to optimize the perspective 
calibration by correcting the misalignment errors existing in the measurements between the light 
sheet location and the CCD array in the camera.  This procedure was completed for each location 
to update the manual calibration files.  A series of AutoMapping iterations was performed (as 
defined in the Insight 3G manual) until the parameters were considered converged and the final 
pixel to length conversion factor calculated.  Figure 4.15 represents the results of the stereo 
AutoMapping procedure for the 2
nd
 laser sheet location in the healthy model.  It is seen that after 
the 4
th
 iteration, the parameters have converged with the number of valid vectors maximized. 
 
 
 
 
 
Based on the stereo AutoMapping results, the perspective calibration files were updated.  Figure 
4.16 represents the updated calibration file that was used for processing the 2
nd
 location images.  
It can be seen (when compared to Figure 4.13) that the linear conversion factor increased from 
Figure 4.15 - Stereo AutoMapping results for the 2nd location in the healthy model. 
A B 
Figure 4.17 - Processing mask for the (A) 4th and (B) 6th 
locations in the healthy model. Figure 4.16 - Perspective calibration for the 
2
nd
 location after stereo AutoMapping. 
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60.07 µm / pixel to 60.18 µm / pixel in (shown in the red boxes from Figure 4.13 to Figure 4.16) 
and is used when converting the particle displacements from pixels to physical length.  This 
small change in conversion factors is an indication that the measurements obtained from the 
setup used to create the initial perspective calibration were correct.  Each location also requires a 
unique processing mask.  This determines which regions of the raw images to analyze.  Vectors 
outside of the physical model are of no interest, and, to reduce processing time, are not included 
in the processing.  Therefore, at each location, an outer boundary is drawn on the raw images to 
represent which regions to process.  As an example, Figure 4.17 illustrates the processing mask 
applied at two different locations (shown as the dotted lines). 
 
4.4.3 – StereoPIV Processing Parameters 
With the AutoMapping completed with the 
final conversion factor calculated (Figure 
4.16) and processing mask applied, each of 
the laser locations were then processed to 
extract particle displacements and velocity 
vectors.  A correlation based PIV processor 
algorithm (Insight 3G default) was used to 
analyze the image pairs.  A recursive 
Nyquist grid engine was chosen to increase 
the accuracy and spatial resolution of the results by processing the images in two passes with 
50% grid overlapping.  The correlations were calculated using Fast Fourier Transforms (FFT) 
while the correlation peaks were located by 
fitting a Gaussian curve to the highest pixel 
and its four nearest neighbors.  Figure 4.18 
shows the stereoPIV processor setup used for 
the healthy human model, while Figure 4.19 
represents the post processing parameters 
used for analysis.  With all of the necessary 
parameters defined, each image set was 
analyzed using a known deltaT of 0.08 
Figure 4.18 - StereoPIV processor used for image processing. 
A B 
Figure 4.19 - (A) Local vector validation parameters and 
(B) vector conditions parameters for processing. 
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seconds (pulse frequency of 12.5 Hz).  Results for the healthy model are found in Chapter 6. 
 
4.5 – Emphysemic Human Analysis Settings 
A total of twelve data laser sheet locations were selected for the emphysemic human model.  The 
laser sheet was initially positioned just inside the model then moved in 3.2 mm (1/8”) intervals, 
collecting data at every new sheet 
location.  Similar to the healthy 
model, the distance from the 
object to the image was measured 
at every laser location and used to 
create a unique perspective 
calibration file for every distance 
(distance from the light sheet to 
the CCD array in the camera).  
Figure 4.20 illustrates the flow conditions applied to the emphysemic model at every sheet 
location to match the in vivo flow conditions (4 second breathing period and expansion of 30%). 
 
Table 4.2 shows the measurements obtained for each of the laser sheet locations analyzed.  The 
process described in section 4.4.3 for processing of the healthy images was applied to the 
emphysemic model while the emphysemic model results are found in Chapter 6. 
 
Table 4.2 - Measurements obtained for each laser sheet location analyzed for the emphysemic model. 
 
Mirror Location (mm) Distance Object to Image (mm) 
2ndLocation 73.8 639.8 
4thLocation 67.5 646.1 
6thLocation 61.1 652.5 
8thLocation 54.8 658.8 
10thLocation 48.4 665.2 
Figure 4.20 - LabVIEW output for an emphysemic human experiment 
displaying the input parameters required to match in vivo conditions (4 
second period and 30.08% expansion resulting in an inhale flow rate of 
1.94 mL/sec). 
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Chapter 5: Experimental Validation 
 
5.1 – CFD Expanding Boiling Flask Model 
In order to validate the experimental stereoPIV setup, a simplified geometry was first tested 
experimentally and compared with computational results. 
 
5.1.1 – Model Creation 
A boiling flask model was created in SolidWorks 
using the outer dimensions of a 50 mL glass 
boiling flask (Figure 5.1).  The two vertical blue 
lines in the model represent the different planes 
that were analyzed.  The first plane (plane that the 
laser sheet goes through in the model) was 
located in the center of the model, while the 
second plane was 11 mm from the center. 
 
5.1.2 – Fluent Simulation 
 
5.1.2.1 – Input Parameters 
A constant flow rate of 3.20 mL/sec was applied to the model for 2.5 seconds.  This represents 
an 8 mL increase in volume corresponding to 9.5% expansion of the model.  These conditions 
were chosen to allow for proper expansion of the bulb model mesh.  Because portions of the 
mesh were stationary throughout the simulation while other regions were continually expanding 
and changing positions, the risk of overlapping of the mesh existed, which would cause failure of 
the simulation.  For this boiling flask mesh, a percent expansion of ≤  16.5% was desired to 
prevent overlapping or negative volume detection in the model.  Therefore, an arbitrary 
expansion of 9.5% was chosen. 
 
A 3D, unsteady, pressure based solver was used in Fluent to simulate the boiling flask model.  
Glycerin was defined as the fluid material with a density, ρ, of 1264.02 kg/m3 and a dynamic 
A B 
Figure 5.1 - (A) Glass boiling flask and (B) SolidWorks 
model used for CFD simulations. 
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viscosity, µ, of 1.15 kg/m-s.  Three dynamic zones were defined for the bulb: the inlet (stationary 
top surface of the duct where the inlet flow rate was applied), a moving zone (all nodes making 
up the circular geometry of the bulb where expansion of the nodes occurs (shown as the blue 
portion of the model in Figure 5.1B)), and a deforming zone (portion of the model that connects 
the stationary inlet to the moving boundary (shown in grey in Figure 5.1B)).  The motion of the 
moving boundary zone was defined in the user-defined function (UDF).  The model was re-
meshed in-between each iteration to minimize skewness of the elements and to allow the mesh to 
update to the moving contours of the model.  A second order upwind scheme was used to 
interpolate the momentum term while a second order scheme was selected for the pressure terms.  
A PISO algorithm was used for the pressure correction.  Under-relaxation factors of 0.2, 0.8, 0.8, 
and 0.5 were chosen for pressure, density, body forces, and momentum, respectively, to aid in 
the convergence of the solution.  In order to check convergence of the fluids equations, residuals 
(continuity, x-velocity, y-velocity, and z-velocity) were monitored with a convergence criterion 
of 1E-4.  Finally, a time step of 0.01 seconds was applied for 250 steps with a maximum of 1000 
iterations per time step and the solution was saved at each flow time occurring throughout the 
simulation (every 0.01 seconds). 
 
5.1.2.2 – Fluent UDF 
In order to expand and contract the boiling flask model in Fluent, similar to the motion existing 
in the experimental setup, a UDF (user-defined function) was modified from a previous version 
presented by our group (Harding and Robinson 2010).  The solution was initialized which reads 
the input flow rate array file (constant flow rate of 3.20 mL/sec) and calculates the initial volume 
of the model.  The grid motion routine starts, which updates the volume of the mesh by iterating 
until the correct expanded volume (also known as the target volume) is met.  This procedure 
calculates the target volume of the model based on the input flow rate and the current time step.  
The model is then uniformly deformed in small increments until the percent difference between 
the current volume and the target volume is less than 1E-5.  This is done by moving all of the 
nodes in the moving boundary zone adjacent to the surface the same calculated amount.  
Specifically, the nodes are displaced by ((target volume – current volume) * 1E-6) m every 
iteration within each time step until the model has expanded to the calculated target volume for 
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the given time step.  Once the grid has been updated to the calculated target volume for a 
particular time step, the Navier-Stokes and continuity equations are solved using an iterative 
process.  A maximum of 1000 iterations occur until the solution is converged for a given time 
step; occurring when the residuals reach 1E-4 (continuity, x-velocity, y-velocity, and z-velocity).  
For the physical times analyzed, all velocity profiles were converged in less than the 1000 
allowable iterations.  An end routine is then completed to append all important data to text files.  
This includes the target and current volumes, residuals, and the volume and mass flow rate data 
for the given time step.  The flow time is then increased by the time step (0.01 was used for this 
analysis) and the grid motion routine is restarted followed by the fluid solutions.  The above 
iterative process of grid motion and fluid solutions is then continued until all of the specified 
time steps have been completed.  Figure 5.2 represents a flowchart of the UDF that was written 
to expand and contract the boiling flask model. 
 
 
No
Update Mesh
(Grid Motion Routine)
Calculate Target 
Volume
Uniformly Deform Mesh
Target Volume Met?
Calculate 
Current Volume
Iterate Fluids Equations
Yes
Max Iterations?
Convergence Met? End RoutineYes
YesNo
Append Data to File
Max Time Steps? Solution CompleteYes
Increase Flow Time by 
Time Step
No
Start Iteration
Define Time Step and 
Max Iterations
No
Read Input Flow 
Rate
Calculate Initial Volume
Define in Fluent:
Solver
Material Properties
Operating Conditions
Boundary Conditions
Dynamic Mesh
Solution Controls
Residual Monitors
Start Initialization
End Initialization
Compile UDF
Fluent Process
UDF Process
Figure 5.2 - Flowchart of UDF written to expand and contract boiling flask model. 
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5.1.3 – Mesh Independence 
In order to determine the proper mesh size for CFD simulations, a mesh independence study was 
completed on various grid sizes.  The six different base mesh parameters that were created in 
Harpoon (Sharc Ltd., Manchester, UK) are shown in Figure 5.3.  The number of cells in the 
mesh models ranged from 32,253 (for a base of 1.4) to 95,762 cells (for a base of 0.85).  Each 
mesh was created with hex dominant element types. 
 
 
Figure 5.3 - Various base meshes created in Harpoon. 
 
Each of the six meshes was simulated in Fluent using the same flow conditions described in 
5.1.2.1  The code used to simulate the expanding bulb is described in Section 5.1.2.2. 
 
To check grid independence of the velocity profiles occurring throughout the model, velocities 
were extracted along two locations in the bulb for each mesh size.  The top rake (line at which 
velocities are extracted at uniform intervals) was taken in the stationary duct (at y = 54.5 mm 
from the bottom of the bulb), while the second rake was extracted in the expanding bulb at the 
location of the diameter (at y = 26.8 mm from the bottom of the bulb).  The normalized velocity 
profiles at both rake locations for all six meshes can be seen in Figure 5.4. 
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It can be seen in Figure 5.4 that the velocity profiles are grid independent for mesh base levels 
less than or equal to 1.0.  The red triangles (mesh = 0.85), black circles (mesh = 0.90), and black 
dotted line (mesh = 1.0) are overlapping; representing a grid independent solution.  Therefore, a 
mesh size of 0.90 was chosen for final analysis and is shown in Figure 5.5 (see Figure 5.3 for the 
chosen mesh properties). 
 
 
 
5.1.4 – CFD Results 
An arbitrary flow time of 1.0 second was chosen to compare CFD to experimental results 
(corresponding to the 100
th
 CFD case file when using a time step of 0.01 seconds).  As described 
A B 
Figure 5.4 - Velocity profiles at time = 1.0 second for varying base level meshes occurring (A) in the stationary duct 
(y = 54.5 mm) and (B) in the center of the moving wall bulb (y = 26.8 mm). 
Figure 5.5 - (A) Harpoon 0.90 base level mesh of the bulb.  (B) Top mesh view of a cross section of the center of the 
model and (C) side view of the center cross section of the model. 
A B C 
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above, two plane locations were chosen for analysis.  In each plane, the velocity profiles were 
compared at two rake locations.  The top and bottom rakes were taken 13.4 mm and 3.4 mm 
above the location of the diameter of the bulb, respectively, for both the 1
st
 and 2
nd
 plane 
locations (Figure 5.6). 
 
 
 
5.1.4.1 – 1
st
 Location – Center Plane of Bulb 
Figure 5.7 represents the Fluent grid displaying the 
locations of the top and bottom rakes for the 1
st
 location 
plane (occurring in the center plane of the bulb).  An 
evenly spaced rake of 20 data points was extracted for 
both the top and bottom rakes.  The CFD velocity profiles 
corresponding to the 1
st
 location (center plane of the bulb 
model) top and bottom rakes can be seen in Figure 5.8 
(for a flow time of 1.0 second).  The positions (x-axis) 
were normalized to allow for comparison between the 
CFD and experimental results. 
 
For comparison, a second flow time of 0.5 seconds was analyzed for the same rake locations as 
specified above.  The velocity fields occurring at this time for the 1
st
 location can be seen in 
Figure 5.9.  It is noted that the velocity magnitudes vary only slightly from time = 0.5 seconds to 
A B C 
Figure 5.6 - (A) View representing both laser sheet planes, (B) view displaying the two rake locations, and (C) front 
view of the model showing all four rake locations. 
Figure 5.7 - Fluent grid showing top and 
bottom rakes. 
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time = 1.0 second.  Because the model is expanding 9.5% over 2.5 seconds, the extents and 
dimensions of the bulb are changing by very small amounts throughout the expansion.  
Therefore, at a given rake location (constant y location from time = 0.5 seconds to time = 1.0 
second), the extents of the bulb change slightly from 0.5 seconds to 1.0 second, and the velocity 
magnitudes remain similar between the two times (an average of 3.5% difference in magnitude 
between the top rake of time = 1.0 second and the top rake of time = 0.5 seconds and an average 
of 2.4% difference between the bottom rake of time = 1.0 second and the bottom rake of time = 
0.5 seconds). 
 
 
 
A B 
Figure 5.8 - Velocity profile plots at the 1st location (center plane of the bulb) for the (A) top rake (y = 13.4 mm 
above the diameter) and (B) bottom rake (y = 3.4 mm above the diameter) for time = 1.0 second. 
A B 
Figure 5.9 - Velocity profile plots at the 1st location (center plane of the bulb) for the (A) top rake (y = 13.4 mm 
above the diameter) and (B) bottom rake (y = 3.4 mm above the diameter) for time = 0.5 seconds. 
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5.1.4.2 – 2
nd
 Location – 11 mm from Center Plane of Bulb 
A second laser sheet location was chosen 11 mm offset 
from the center plane of the bulb for further validation 
(Figure 5.6A).  Figure 5.10 shows the Fluent grid 
corresponding to the 2
nd
 location where the top and 
bottom rake locations are visible (occurring at y = 13.4 
mm and y = 3.4 mm above the diameter, respectively).  
The CFD velocity profiles corresponding to the 2
nd
 
location and a flow time of 1.0 second can be seen in 
Figure 5.11.  Similarly, the Fluent results for the 2
nd
 
location occurring at a flow time = 0.5 seconds are shown 
in Figure 5.12.  Again, the positions were normalized to 
allow for comparisons between the CFD and experimental results. 
 
 
 
Again, it is seen that the magnitudes between time = 0.5 seconds and time = 1.0 second vary 
slightly for a given rake location.  For the 2
nd
 location, the magnitudes vary by an average of 
1.9% between the top rake of time = 1.0 second and the top rake of time = 0.5 seconds and an 
average of 1.8% between the bottom rake of time = 1.0 second and the bottom rake of time = 0.5 
seconds. 
B A 
Figure 5.11 - Velocity profile plots at the 2nd location (11 mm from the center of the bulb) occurring at a 
flow time of 1.0 second for the (A) top rake (y = 13.4 mm above the diameter) and (B) bottom rake (y = 3.4 
mm above the diameter). 
Figure 5.10 - 2nd Location showing top and 
bottom rakes. 
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5.2 – Experimental Methods Used for Validation 
 
5.2.1 – Compliant Model Creation 
Using the modeling techniques previously described in section 2.6, multiple compliant models of 
the boiling flask bulb were obtained.  A single model was 
chosen for final analysis based on the quality of the model.  
Specifically, the most uniform model was chosen with the least 
amount of air bubbles or voids in the Ultraflex material; 
reducing the amount of laser refraction occurring throughout 
the model.  The model was attached to the fitting in the 
experimental housing and filled with a glycerin/particle mix 
(approximately 0.007 grams / 150 mL of glycerin).  Figure 5.13 
represents the experimental boiling flask model used for 
stereoPIV validation.  Note that the complaint model in Figure 
5.13 is sitting on a flat surface so the bottom appears to be flat on the bottom. 
 
5.2.2 – Experimental Setup 
The experimental techniques descried in Chapter 4 were applied to the boiling flask model for 
validation with the experimental setup shown in Figure 4.8.  Similar to the CFD analysis, a 
A B 
Figure 5.12 - Velocity profile plots at the 2nd location (11 mm from the center of the bulb) occurring at a 
flow time of 0.5 seconds for the (A) top rake (y = 13.4 mm above the diameter) and (B) bottom rake (y = 
3.4 mm above the diameter). 
Figure 5.13 - Compliant boiling 
flask model used for validation 
(model is sitting on flat surface).   
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constant flow rate of 3.20 mL/sec was applied to the experimental boiling flask model 
(representing 9.5% expansion).  Each of the cameras was set to 17° from the perpendicular of the 
light sheet (34° between cameras).  In order to locate the center of the model for the 1
st
 location 
analysis, the laser sheet was positioned at the diameter of the model (just inside the model 
membrane), then moved back towards the center 27.2 mm (the radius of the model).  The 
distance from the object to the image was measured to be 25.75” (distance from the laser sheet 
plane to the CCD array in the camera).  As stated above, the second laser sheet location was 11 
mm from the center of the bulb model.  The laser optics were moved 11 mm from the center 
location and the distance from the object to the image measured to be 25.30”. 
 
5.2.4 – Insight 3G 
The methods described in Chapter 4 were used to acquire and process the stereoPIV images for 
experimental validation.  The settings used in the validation experiments are described in the 
following sections. 
 
5.2.4.1 – Image Capture 
Figure 5.14 represents the capture timing settings used to capture the validation images.  Because 
the fluid flow is considered slow flow, single capture was used with a pulse rate of 20 Hz (deltaT 
of 0.05 seconds between each frame).  To reduce 
the effects of ambient light, an exposure time of 
200 µs was used for each of the cameras.  A 
trigger was used to configure the start of the 
image capture with the start of the LabVIEW 
pump motion (see Figure 4.9).  Because a period 
of 5 seconds was used, a total of 100 pictures 
were required (20 pictures/second), but 105 
images were actually captured to account for any 
residual fluid motion.  In order to illustrate the 
repeatability of the experimental setup, three sets 
of data were taken for each of the two laser sheet locations.  After each set of data was obtained, 
Figure 5.14 - TSI capture settings used for 
experimental validation. 
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the file names of the images were updated to represent image numbers (numbered from 0 to 
104).  Using a laser pulse delay of 100 µs and a deltaT of 50,000 µs, image pair 19 to 20 
corresponds to a flow time of 1.0 second while pair 9 to 10 corresponds to a flow time of 0.5 
seconds. 
 
5.2.4.2 – Creating Calibration Files 
Before image processing was started, optical calibrations were manually created to account for 
the magnification changes that occurred from one side of the image to the other (see section 
4.4.1).  The parameters used to create the 1
st
 and 2
nd
 location perspective calibration files are 
shown in Figure 5.15 and Figure 5.16, respectively.  For example, the distance from the laser 
sheet (object) to the CCD array (image plane) was measured to be 654.05 mm for the 1
st
 
location.  The values in the red boxes represent measured distances and angles acquired from the 
experimental setup while the purple boxes represent fixed specifications from the cameras used.  
The camera locations (blue boxes) were calculated by Insight based on the values from the red 
and purple boxes and were verified by measuring the distance from the light sheet to the front of 
the camera lens. 
 
      
 
Figure 5.16 - Perspective calibration parameters used 
for 2nd location. 
Figure 5.15 - Perspective calibration parameters used 
for 1st location. 
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A stereo AutoMapping procedure was then completed to optimize the perspective calibration by 
correcting the misalignment errors existing in the measurements between the light sheet location 
and the CCD array in the camera.  This procedure was completed for each location to update the 
manual calibration files.  A series of AutoMapping iterations was performed until the parameters 
were considered converged and the final pixel to length conversions calculated.  Figure 5.17 
represents the AutoMapping results for both laser sheet locations.  It is seen that after the 4
th
 
iteration, each of the results were converged. 
 
 
Figure 5.17 - Stereo AutoMapping results for the (Top) 1st location and (Bottom) 2nd location. 
 
 
Figure 5.18 - Final calibration files for (Left) 1st location and (Right) second location after 
stereo AutoMapping.  The red boxes represent the final conversion factors. 
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With the stereo AutoMapping results recorded, the calibration files were updated and shown in 
Figure 5.18.  It is seen that the pixel to length conversion for the 1
st
 location is 60.56 µm and 
58.44 µm for the 2
nd
 location.  These conversions from pixels to physical distances are referred 
to here after as conversion factors. 
 
5.4.2.3 – StereoPIV Processing Parameters 
A processing mask was applied for each location to represent a processing boundary.  All 
particles inside the boundary were 
analyzed while everything outside 
was ignored.  Figure 5.19 
represents the processing masks 
used for both the 1
st
 and 2
nd
 
locations (shown as the dotted 
line).  The image processing 
parameters described in section 
4.4.3 were applied to the boiling flask model.  Using a deltaT of 50,000 µs, each of the image 
sets was analyzed with the appropriate optical calibration and processing mask applied. 
 
5.2.5 – StereoPIV Results Compared to CFD 
 
5.2.5.1 – 1st Location – Center Plane of Bulb 
Three different data sets were collected for the 1
st
 laser sheet location.  Figure 5.20 displays the 
LabVIEW outputs from the three sets of collected data. 
 
 
A B C 
Figure 5.20 - LabVIEW outputs for the 1st locations (A) 1st set, (B) 2nd set, and (C) 3rd set. 
A B 
Figure 5.19 - Processing masks for (A) 1
st
 location and (B) 2
nd
 location. 
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Corresponding to the rakes taken from the CFD results, velocity profiles were extracted for each 
of the data sets at two rake locations.  The top and bottom rakes were taken 13.4 mm and 3.4 mm 
above the location of the diameter of the bulb, respectively.  Figure 5.21 displays the locations of 
the top and bottom rakes with velocity vectors contoured by velocity magnitude. 
 
Figure 5.22 represents the stereoPIV 
velocity profiles for time = 1.0 second 
for both the top and bottom rake 
locations (y = 13.4 mm above the 
diameter and y = 3.4 mm above the 
diameter, respectively), while Figure 
5.23 represents the results occurring at 
time = 0.5 seconds.  The results from 
all three collected data sets are shown 
on the same plot to illustrate the 
repeatability of the stereoPIV 
experiments.  It is shown that the 
experiments are repeatable because the 
sets are overlapping (dotted line 
represents 1
st
 set, solid line represents 2
nd
 set, and circles represent the 3
rd
 set). 
 
Similar to the CFD results (section 5.1.4.1), the velocity magnitudes of the stereoPIV results 
should vary only slightly between time = 1.0 second and time = 0.5 seconds (1.8% difference for 
CFD predictions).  It is seen, however, that the experimental average maximum y-velocity 
magnitude between the top rake of time = 1.0 seconds (average velocity = -4.76E-3 m/s) and top 
rake of time = 0.5 second (average velocity = -4.44E-3 m/s) varies by 7.0%.  This indicates that 
the experimental results between different physical times can vary by approximately 7.0% with 
the larger times having better agreement with the predicted results. 
 
Figure 5.21 - Top and bottom rake locations for the 1st laser sheet 
location (center of the bulb model). 
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Absolute differences and percent differences relative to velocity magnitude (based on maximum 
velocities) were calculated between stereoPIV and predicted CFD results for each velocity 
component and are shown in Table 5.1 and Table 5.2, respectively. 
 
 
 
 
 
 
 
 
 
B A 
Figure 5.23 - StereoPIV velocity profiles for time = 0.5 seconds with the predicted CFD results (shown as black 
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4 
mm above the diameter) for the 1
st
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-
velocity, Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
Figure 5.22 - StereoPIV velocity profiles for time = 1.0 second with the predicted CFD results (shown as black solid 
lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4 mm 
above the diameter) for the 1
st
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-
velocity, Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
A B 
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Table 5.1 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using 
the conversion factor calculated in Insight 3G.  (VM = velocity magnitude) 
 
 
Table 5.2 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and 
predicted CFD results using the conversion factor calculated in Insight 3G.  (VM = velocity magnitude) 
 
 
The error in Table 5.1 was reduced by examining the conversion factor.  An optical test was 
completed to verify that the conversion being calculated in Insight was correct and to insure that 
the index 
matching between 
the compliant 
model and the 
carrier fluid was 
sufficient; not 
introducing error 
to the results.  
With the boiling 
flask model 
installed in the experimental housing, a scale was inserted at the center plane of the model and an 
image acquired.  The model was then removed from the setup and the scale replaced to obtain a 
A B 
Figure 5.24 - (A) Scale inserted into compliant model and (B) scale removed from model.  
(Both occur in the center plane of the model) 
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second image (Figure 5.24).  Table 5.3 represents the measured distances, the number of pixels 
that represents the known lengths (calculated in ImageJ), and the resulting pixel to length 
conversion factors corresponding to the colored lines in Figure 5.24. 
 
Table 5.3 - Measured distances corresponding to the colored lines in Figure 5.24. 
 
 
An average measured pixel to length conversion factor was then calculated and compared to the 
conversion factor used for the above analyses.  It is clear from the similarities in pixel to length 
conversions from each of the two conditions that we successfully indexed matched the compliant 
model material with the carrier fluid.  We can also conclude that large errors are not being 
introduced between the CFD and experimental results because of refraction.  However, the 
previous conversion calculated in Insight was 60.56 µm/pixel for the first location (Figure 5.18), 
but the newly measured conversion was 64.23 µm per pixel (a 6% difference).  This difference in 
conversion factors introduces a significant amount of error because the sizes of the images are 
1324 x 1024 (Figure 5.18).  The 4 µm per pixel difference between the Insight and the measured 
conversion factors leads to a 5.3 mm difference in the width of the image and a 4.1 mm 
difference in the height of the image. 
 
Particle displacements are measured in pixels then converted to physical lengths to finally 
calculate velocities.  If an inconsistency exists in the conversion factor the velocity magnitudes 
will be incorrect.  Therefore, the stereoPIV results from the above analyses were scaled based on 
new measured conversion factor and compared to the predicted CFD results.  For example, each 
velocity vector from Figure 5.22 and Figure 5.23 was multiplied by the ratio of the new 
conversion factor to the old (64.23 / 60.56).  Figure 5.25 and Figure 5.26 represent the stereoPIV 
velocity profiles compared to the predicted CFD results using the newly measured conversion 
factor for time = 1.0 second and time = 0.5 seconds, respectively.  It is seen that the velocity 
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magnitudes agree better with the predicted CFD results using the measured conversion factor.  
Table 5.4 and Table 5.5 represent the absolute differences and percent differences relative to 
velocity magnitude (based on maximum velocity) that exist between the stereoPIV and predicted 
CFD results when using the newly measured conversion factor; indicating that the percent 
differences have decreased.  For example, the relative percent difference between the y-velocity 
component for the top rake at time = 1.0 second decreases from 10.7% to 5.4% when using the 
measured conversion factor. 
 
 
 
B A 
Figure 5.25 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 64.24 µm) for time = 1.0 
second with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom rake 
location for the 1
st
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, Green = z-
velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
A B 
Figure 5.26 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 64.24 µm) for time = 0.5 
seconds with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom 
rake location for the 1
st
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, 
Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
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Table 5.4 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using 
the measured conversion factor.  (VM = velocity magnitude) 
 
 
Table 5.5 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and 
predicted CFD results using the measured conversion factor.  (VM = velocity magnitude) 
 
 
5.2.5.2 – 2nd Location – 11mm from Center Plane of Bulb 
Figure 5.27 displays the LabVIEW outputs from the three sets of collected data for the 2
nd
 laser 
sheet location (11 mm from the center plane of the bulb). 
 
 
Figure 5.28 represents the locations of the top and bottom rakes with repsect to the diameter of 
the model for the 2
nd
 laser sheet location.  Similar to the 1
st
 laser sheet location, the top rake 
A B C 
Figure 5.27 - LabVIEW outputs for the 2nd locations (A) 1st set, (B) 2nd set, and (C) 3rd set. 
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occurs 13.4 mm above the diameter while the bottom rake is 3.4 mm above the diameter of the 
bulb.  Velocity vectors contoured by velocity 
magnitude are also displayed. 
Using the calculated Insight 3G conversion 
factor for the 2
nd
 location (1 pix = 58.44 µm), 
Figure 5.29 and Figure 5.30 represent the 
stereoPIV with the predicted CFD results for 
time = 1.0 second and time = 0.5 seconds, 
respectively.  Table 5.6 and Table 5.7 represent 
the absolute differences and percent differences 
relative to velocity magnitude (based on 
maximum velocities) between the stereoPIV and 
predicted CFD results for each component of 
velocity, respectively.  
 
 
 
A B 
Figure 5.29 - StereoPIV velocity profiles for time = 1.0 second with the predicted CFD results (shown as black 
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4 
mm above the diameter) for the 2
nd
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-
velocity, Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
Figure 5.28 - Top and bottom rake locations for the 2nd 
laser sheet location. 
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Table 5.6 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using 
the conversion factor calculated in Insight 3G.  (VM = velocity magnitude) 
 
 
Table 5.7 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and 
predicted CFD results using the conversion factor calculated in Insight 3G.  (VM = velocity magnitude) 
 
 
Similar to the 1
st
 laser sheet location, a new calibration conversion was desired to check the 
accuracy of the calculated factor (currently 58.4 µm/pixel).  However, at the 2
nd
 location, a scale 
A B 
Figure 5.30 - StereoPIV velocity profiles for time = 0.5 seconds with the predicted CFD results (shown as black 
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4 
mm above the diameter) for the 2
nd
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-
velocity, Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
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was unable to be inserted into the housing.  Therefore, multiple locations outside of the setup 
were captured to establish a trend then interpolated at the 2
nd
 location.  The measured conversion 
factor was found to be 61.36 µm.  Figure 5.31 and Figure 5.32 represent the stereoPIV velocity 
profiles compared to the predicted CFD results using the newly measured conversion factor for 
time = 1.0 second and time = 0.5 seconds, respectively. 
 
 
 
Table 5.8 and Table 5.9 represent the differences (absolute and percent difference relative to 
velocity magnitude) that exist between the experimental and predicted CFD results using the 
A B 
Figure 5.31 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 61.36 µm) for time = 1.0 
second with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom rake 
location for the 2
nd
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, Green = 
z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
A B 
Figure 5.32 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 61.36 µm) for time = 0.5 
seconds with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom 
rake location for the 2
nd
 laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, 
Green = z-velocity.  Different sets are indicated by dashed lines, solid lines, and circles). 
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measured conversion factor, respectively.  Again, an overall better agreement was found between 
the stereoPIV and the predicted CFD results when using the measured conversion factor. 
 
Table 5.8 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using 
the measured conversion factor.  (VM = velocity magnitude) 
 
 
Table 5.9 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and 
predicted CFD results using the measured conversion factor.  (VM = velocity magnitude) 
 
 
5.3 – Conclusions About Boiling Flask Experiments 
The above analyses have shown that the experimental setup and processes being used to acquire 
and analyze stereoPIV data yield accurate results.  Several conclusions and suggestions have 
been made for future analyses and are summarized below: 
 A constant applied flow rate should be used to expand and contract the experimental 
model to maximize control of the expansion.  This flow rate should be at least 3 mL/sec to 
allow for the appropriate pixel displacements to occur between each image set (using a 
deltaT of 0.05 seconds between each image).  An alternative to increasing the flow rate 
would be to decrease the laser pulsing frequency (currently 20 pulses / sec).  If the frequency 
were decreased, the deltaT between frames would increase, and a larger displacement would 
occur between sequential image sets. 
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 When creating a manual perspective calibration file (calculated by Insight), it is 
important to correctly measure and enter the appropriate distance from the image to the 
object.  If this distance is off by a slight amount, the conversion from pixels to physical 
length (conversion factor) will be incorrect and will lead to large differences in the velocity 
magnitudes.  It is also important to create a measured conversion factor and scale the results 
by the ratio of the measured to the calculated factor to correct any errors that may be induced 
by the conversion factor calculated by Insight (see section 5.2.5.1) 
 In order to properly capture the motion of the seeded particles, a minimum of five to 
eight pixels must be displaced between an image pair.  Therefore, velocity profile rakes are 
more accurate when extracted at locations that yield high particle displacement (typically 
near the inlet). 
 As seen between the results from time = 1.0 second to time = 0.5 seconds, a larger 
physical time is desired for more uniform and accurate results. 
 The presence of large error for the z-component of velocity between the stereoPIV and 
predicted CFD results is occurring because the camera angles from the light sheet were not 
optimized.  As explained in section 4.1, a camera angle is ideal as to capture the pure z-
component of velocity.  However, because the angles used in this work were relatively small 
(to allow for the image in the light sheet to be in focus from one side of the image to the 
other), the accuracy of the z-component was significantly reduced.  If future work is 
completed, the use of Scheimpflug mounts is recommended.  These would allow the camera 
angles to be maximized without sacrificing the quality of the images and yield the smallest z-
component errors. 
 Be aware of the non-uniform expansion that exists in the experimental setup.  If the 
model tends to expand towards the pump location, the skew depicted in Figure 5.33 will 
occur (the velocity on the left side will be less than predicted and the velocity on the right 
will be slightly higher than predicted).  The solid red line indicates where the rake should be 
occurring.  If uniform expansion was occurring, the rake would be a straight line across the 
model (left image).  However, if the expansion is non-uniform, the location of the rake is no 
longer horizontal and the dotted line would represent the actual rake location.  The blue 
arrows indicate that the actual rake yields less than predicted velocities on the left side of the 
model with higher velocities occurring on the right side.  The effects of non-uniform 
65 
 
expansion are illustrated in the above results section (section 5.2.5).  Figure 5.29, for 
example, shows velocities less than predicted on the left side of the model, but higher than 
predicted on the right side; an indication of non-uniform expansion of the experimental 
model. 
 
 
Figure 5.33 - Difference in velocity profile caused by non-uniform expansion. 
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Chapter 6: StereoPIV Results in Alveolus Models 
 
6.1 – Experimental Healthy Human Model 
A total of forty-two data sets were collected for the healthy human model; three sets of data for 
each of the fourteen different laser plane locations.  In order to illustrate the three-dimensional 
effects of all of the results, six laser locations were analyzed and compared.  Figure 6.1 
represents the isometric and top views of the approximate locations chosen for analysis. 
 
 
 
6.1.1 – Locations of Potential Recirculation 
When collecting stereoPIV data, care was taken in choosing which laser sheet planes to analyze.  
Regions where recirculation would be most likely to 
occur were desired.  According to literature, flow rate 
ratios (ratio of the alveolar to duct flow rate) 
approximately below 0.05 produce recirculating flows 
(Tippe and Tsuda 2000; Tsuda et al. 1995; Kumar et al. 
2009b).  These small ratios exist where the ductal flow 
is large compared to the alveolar flow, or in regions 
where the alveolar mouth diameter is small compared to 
the alveolar depth.  It was clear from observation that 
there was no overwhelming flow directly adjacent to the mouth diameter of the alveoli.  All of 
A B 
Figure 6.1 - (A) Isometric and (B) top views of the chosen locations for data analysis for the healthy human model. 
6
th
 Location 
8
th
 Location 
Figure 6.2 - Regions where recirculation 
would be most likely to occur. 
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the flow traveled into the alveoli with the contours of the model, essentially yielding an infinite 
alveolar to ductal flow ratio.  Therefore, we focused on the geometry differences in this study 
rather than the flow rate ratios. 
 
 
 
 
 
6th Location 8th Location 
Figure 6.3 - Raw PIV images (showing the distribution of particles) of the 6th and 8th 
locations representing regions where recirculation would occur. 
B 
Figure 6.4 - Zoomed in views of the (A) vector and (B) streamline plots (contoured by velocity magnitude) for the 
6th location in the healthy human model (refer to Figure 6.1 for the 6th location with respect to the whole model). 
A 
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Of the data collected from the fourteen laser plane locations in the healthy model, the 6
th
 and 8
th
 
locations displayed geometry that would be most likely to induce recirculation.  Figure 6.2 
illustrate the regions in the healthy model where 
recirculating eddies would be most likely to occur.  
Figure 6.3 represents the raw PIV images illustrating 
particle dispersion of the two locations seen in Figure 
6.2.  The circular regions display the small pouches 
that would most likely induce recirculation.  The 
following results first reveal the flow fields that exist 
at these two particular locations and conclude whether 
recirculating or reversible flow is occurring.  Figure 
6.4 represents the velocity and streamline plots for the 
potential recirculation region at the 6
th
 location 
(Figure 6.3).  It is seen that reversible flow is present throughout the entire model, and a 
maximum experimental fluid velocity magnitude of 2.5 mm/s occurs near the center of the 
region.  Reversible flow is concluded because the streamlines do not exhibit any eddy pattern.  
The lines go into the model in a very uniform manner without sharp direction changes.  Figure 
6.5 represents an isometric view of the 6
th
 location vectors (contoured by velocity magnitude), 
illustrating the z-direction (third-dimension) vectors. 
 
 
B A 
Figure 6.6 - Zoomed in views of the (A) vector and (B) streamline plots (contoured by velocity 
magnitude) for the 8th location in the healthy human model (refer to Figure 6.1 for the 8th location 
with respect to the whole model). 
Figure 6.5 - Isometric view of the 6th location 
illustrating the z vectors. 
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Similar in geometry to the 6
th
 location, the 8
th
 location (Figure 6.3) has features that could 
potentially induce recirculation (small alveolar 
mouth diameter).  Figure 6.6 represents the 2D 
velocity field and streamline plots occurring in 
the 8
th
 location of the healthy human model 
(both contoured by velocity magnitude).  
Reversible flow is also found in this location 
because the streamlines are uniform and follow 
the contours of the model boundary (no sharp 
changes in vector direction).  The maximum 
velocity magnitude occurring at this 8
th
 location 
is 6.7 mm/s.  This is larger than the 6
th
 location 
velocity because the 8
th
 location is closer to the 
inlet of the model.  Figure 6.7 represents an isometric view of the velocity vectors occurring at 
the 8
th
 location (contoured by velocity magnitude), illustrating the z-component of velocity. 
 
6.1.2 – 3-Dimensional Flow Fields 
Of the three sets of data collected for each laser location, the second set was chosen to display 
because of the consistency of the results.  Variability existing in the three sets is discussed in 
section 5.2.5.  Figure 6.8 represents the 2D vector results for the second set location analyzed in 
Figure 6.1A.  In order to maximize the resolution of the velocity fields in Figure 6.8, the 
contours were scaled independently for each laser sheet location.  It is seen that as the planar 
location moves closer to the inlet of the model (between locations 8 and 10), the velocities 
maximize.  Based on the constant inlet flow rate applied to the model, the maximum 
experimental velocity occurring in the plane of the inlet is 38.6 mm/sec (1.94 mL/sec flow rate 
with an 8.0 mm duct diameter). 
 
To visualize the three-dimensional results of the healthy human model, Figure 6.9 represents all 
six planar locations analyzed with contours of the global velocity magnitude to illustrate the 
overall range of velocities that exist within the model.  Figure 6.10 displays the same six 
locations but from an exploded view, illustrating both contours and velocity vectors.   
Figure 6.7 - Isometric view of the 8th location 
illustrating the z vectors. 
70 
 
 
 
 
 
A B C 
D E F 
Figure 6.8 - 2D experimental velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd 
through the 12th locations (see Figure 6.1A for locations).  Each image is contoured by velocity magnitude and is 
independent of each location. 
A B 
Figure 6.9 - All six planar locations analyzed showing (A) contours and (B) vectors contoured by the global 
velocity magnitude. 
(The maximum velocity that occurred in the planes analyzed was 0.0095 m/s) 
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Finally, Figure 6.11 displays the top view of the healthy human model results representing the 
magnitude and direction of the z-component of velocity. 
 
It was shown in Chapter 5 that the experimental z-component of velocity varied the most from 
the predicted CFD results.  Therefore, the z-component vectors shown in Figure 6.11 are 
estimates to the behavior of the flow field occurring in the z-direction. 
 
 
A B 
Figure 6.10 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors contoured by 
the global velocity magnitude.  (The maximum velocity that occurred in the planes analyzed was 9.5 mm/sec). 
Figure 6.11 - Top view of the healthy human model 
representing the magnitude and direction of the z-
component of velocity. 
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6.2 – In Vivo Healthy Human Predictions 
 
6.2.1 – Scaling Experimental Healthy Results to In Vivo 
After all of the experimental data was collected, the results were scaled back to represent 
velocity predictions.  The shapes of the flow fields remained the same, but the overall 
magnitudes were affected.  The velocities were scaled using the assumption that the in vivo 
conditions were well represented experimentally (Chapter 3).  Therefore, the non-dimensional 
velocities, u
*
, can be equated by 
 
  
exp
uu
invivo
      (6.1)  
 
The in vivo velocities were predicted using Equation 6.1 by substitution of the non-dimensional 
parameters that were used to derive the Navier-Stokes equations in non-dimensional form 
(Equation 3.1).  Specifically, Uuu  (where U represents the time and spatially averaged 
velocity at the model inlet), such that Equation 6.1 becomes 
 
        
exp
exp
U
U
uu
invivo
invivo
     (6.2)  
 
where 
  
exp
expexp
exp
Re
Re
d
d
uu
invivio
invivoinvivo
invivo
     (6.3)  
 
which can be used to determine the predicted in vivo velocities from the experimental stereoPIV 
measurements. 
 
The in vivo and experimental model properties and flow conditions for the healthy human model 
are shown in Table 6.1 and Table 6.2, respectively.  The Reynolds numbers for normal and 
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heavy in vivo breathing were calculated to be 0.009 and 0.035, respectively.  Using the material 
properties for in vivo and experimental conditions, the experimental velocities were multiplied 
by 0.02469 (Equation 6.3) to achieve the in vivo flow field for a Re of 0.009 and multiplied by 
0.09341 to represent the in vivo field for a Re of 0.035. 
 
Table 6.1 - Model and material properties for the healthy human model. 
Symbol Property 
In Vivo 
(Air at 20°C) 
Experimental 
(Glycerin at 20°C) 
d 
Acinus Inner Duct Diameter 
(mm) 
0.41 8.00 
Vi 
Mean Acinus Volume 
(mm
3
) 
1.25 9013.46 
ν 
Kinematic Viscosity 
(mm
2
/sec) 
17.10 909.80 
 
Table 6.2 - In vivo and experimental flow conditions for the healthy human model. 
  
Time 
Averaged Re 
at Model 
Inlet 
Expansion 
(%) 
Breathing 
Frequency 
(breaths/min) 
Time Average 
Flow Rate at 
Model Inlet 
(mL/sec) 
U, Time and 
Spatially 
Averaged 
Velocity at 
Model Inlet 
(mm/sec)  
In Vivo 
Normal 
Breathing 
0.009 16 15.7 1.30E-04 0.97 
Heavy 
Breathing 
0.035 60 15.7 4.91E-04 3.66 
Experimental 
Used in 
This Work 
0.138 35 15.0 1.94 38.60 
 
Referring to section 2.4, an inlet duct was created for the healthy human model.  The cylindrical 
geometry was added using arbitrary dimensions and created to fit with the surrounding model 
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contours.  When the final model was scaled back to in vivo dimensions, the model was scaled 
based on dimensions of alveoli rather than the arbitrary duct diameter (see Figure 2.16 for the 
dimensions used for scaling to in vivo sizes).  Therefore, the ratio of the experimental diameter to 
the in vivo duct diameter was 19.4 for the healthy model.  Regardless of the dimensions used to 
create the inlet duct, the ratio between any distance for the experimental and in vivo models will 
always be the scaling factor used (if uniform scaling by length is applied to the entire model).  
Because the experimental healthy model was created 19.4x in vivo size, the x, y, and z distances 
were divided by 19.4 to represent the correct scaled in vivo dimensions of the model. 
 
Figure 6.12 represents the scaled in vivo 2D results for all six of the locations analyzed for an in 
vivo Re of 0.009.  Each image is contoured by in vivo velocity magnitude and is independent 
from each location. 
 
 
 
A B C 
D E F 
Figure 6.12 - 2D in vivo velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd 
through the 12th locations (see Figure 6.1A for locations) for Re = 0.009. 
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Figure 6.13 illustrates the in vivo flow fields (for a Re of 0.009) for all six planar locations 
analyzed contoured by the global in vivo velocity magnitude, while Figure 6.14 illustrates the 
exploded view of all six locations. 
 
 
 
 
 
A B 
Figure 6.13 - In vivo results for all six planar locations analyzed showing (A) contours and (B) vectors 
contoured by the global velocity magnitude for Re = 0.009.  (The maximum velocity that occurred in the 
planes analyzed was 0.22 mm/sec) 
A B 
Figure 6.14 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors 
contoured by the in vivo global velocity magnitude for a Re = 0.009.  (The maximum velocity that occurred 
in the planes analyzed was 0.22 mm/sec) 
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Finally, Figure 6.15 illustrates the top view 
of the healthy human model in vivo results 
representing the magnitude and direction of 
the z-component of velocity for a Re of 
0.009.  Figure 6.16 represents the scaled in 
vivo 2D results for all six of the locations 
analyzed for an in vivo Re of 0.035.  Each 
image is contoured by in vivo velocity 
magnitude and is independent from each 
location.  Figure 6.17 illustrates the healthy 
in vivo flow fields (for a Re of 0.035) for all 
six planar locations analyzed contoured by 
the global in vivo velocity magnitude, while 
Figure 6.18 illustrates the exploded view of all six locations. 
 
 
A B C 
D E F 
Figure 6.16 - 2D in vivo velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd 
through the 12th locations (see Figure 6.1A for locations) for Re = 0.035. 
Figure 6.15 - Top view of the healthy human model 
representing the in vivo magnitude and direction of the z-
component of velocity (for Re = 0.009). 
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Finally, Figure 6.19 illustrates the top view of the healthy model representing the in vivo velocity 
magnitude and direction of the z-component of velocity for an in vivo Re of 0.035. 
 
A B 
Figure 6.17 - In vivo results for all six planar locations analyzed showing (A) contours and (B) vectors 
contoured by the global velocity magnitude for Re = 0.035.  (The maximum velocity that occurred in the 
planes analyzed was 0.89 mm/sec) 
A B 
Figure 6.18 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors 
contoured by the in vivo global velocity magnitude for a Re = 0.035.  (The maximum velocity that occurred 
in the planes analyzed was 0.89 mm/sec) 
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6.3 – Experimental Emphysemic Human Model 
A total of thirty-six data sets were collected for the emphysemic human model; three sets of data 
for twelve laser plane locations.  In order to illustrate the three-dimensional effect of all of the 
results, five locations were analyzed and compared.  Figure 6.20 represents the isometric and top 
views of the approximate locations chosen for analysis. 
 
 
 
A B 
Figure 6.20 - (A) Isometric and (B) top views of the chosen locations for data analysis for the emphysemic 
human model. 
Figure 6.19 - Top view of the healthy human model 
representing the in vivo magnitude and direction of the z-
component of velocity (for Re = 0.035). 
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Because of the oversized geometry, as compared to the healthy model, there were no specific 
regions that would suggest recirculation.  No regions existed where the alveolar mouth diameter 
was smaller than the alveolar depth.  Therefore, the results from the entire emphysemic model 
were presented, similar to section 6.1.2 above.  Of the three sets of data collected for each 
location, the third set was chosen to display because of the consistency of the results.  The 
variability occurring between the three sets is discussed in section 5.2.5.  Figure 6.21 represents 
the 2D vector results for all third set locations analyzed in Figure 6.20A. 
 
To visualize the three-dimensional results of the emphysemic human model, Figure 6.22 
illustrates all five planar locations analyzed with contours of the global velocity magnitude. 
 
 
 
A B C 
D E 
Figure 6.21 - 2D velocity vector results for the five analyzed locations (A – E) corresponding to the 2nd 
through the 10th locations (see Figure 6.20A for locations).  Each image is contoured by velocity 
magnitude and is independent of each location. 
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Figure 6.23 displays the same five locations but from an exploded view, illustrating both 
contours and velocity vectors.  Finally, Figure 6.24 displays the top view of the emphysemic 
human model results representing the magnitude and direction of the z-component of velocity. 
 
 
 
 
 
A B 
Figure 6.22 - All five planar locations analyzed showing (A) contours and (B) vectors contoured by the global 
velocity magnitude.  (The maximum velocity that occurred in the planes analyzed was 6.4 mm/sec) 
A B 
Figure 6.23 - Exploded view of all five planar locations analyzed showing (A) contours and (B) vectors contoured 
by the global velocity magnitude.  (The maximum velocity that occurred in the planes analyzed was 6.4 mm/sec) 
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6.4 – In Vivo Emphysemic Human Predictions 
 
6.4.1 – Scaling Experimental Emphysemic Results to In Vivo 
Because the emphysemic model was 8.9x in vivo size (by length scale), the x, y, and z distances 
were divided by 8.9 to represent the scaled in vivo dimensions of the model.  Similar to the 
healthy model, the experimental emphysemic velocities were scaled using Equation 6.3 and the 
model properties in Table 6.3.  Table 6.4 represents the in vivo and experimental flow conditions 
for the emphysemic model.  The Reynolds number for normal in vivo emphysemic breathing was 
calculated to be 0.035.  Using the material properties for in vivo and experimental conditions, the 
experimental velocities were multiplied by 0.04204 (Equation 6.3) to achieve the in vivo flow 
fields for an emphysemic Re of 0.035.  This is smaller than the conversion used for the healthy 
Re of 0.035 because the emphysemic in vivo diameter is 2x larger than the healthy.  Therefore, 
even though the Re are the same, the conversions vary because of the model properties. 
 
 
 
 
Figure 6.24 - Top view of the emphysema human model 
representing the magnitude and direction of the z-component of 
velocity. 
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Table 6.3 - Model and material properties for the emphysemic human model. 
Symbol Property 
In Vivo 
(Air at 20°C) 
Experimental 
(Glycerin at 20°C) 
d 
Acinus Inner Duct Diameter 
(mm) 
0.90 8.00 
Vi 
Mean Acinus Volume 
(mm
3
) 
14.39 10488.60 
ν 
Kinematic Viscosity 
(mm
2
/sec) 
17.10 909.80 
 
Table 6.4 - In vivo and experimental flow conditions for the emphysemic human model. 
  
Time 
Averaged Re 
at Model 
Inlet 
Expansion 
(%) 
BF 
(breaths/min) 
Time Average 
Flow Rate at 
Model Inlet 
(mL/sec) 
U, Time and 
Spatially 
Averaged 
Velocity at 
Model Inlet 
(mm/sec) 
In Vivo 
Normal 
Breathing 
0.035 11 16.0 1.03E-03 1.61 
Experimental 
Used in 
This Work 
0.138 30 15.0 1.94 38.60 
 
Figure 6.25 represents the scaled in vivo 2D results for all five of the locations analyzed for an 
emphysemic in vivo Re of 0.035.  Each image is contoured by in vivo velocity magnitude and is 
independent from each location.  Figure 6.26 illustrates the healthy in vivo flow fields (for a Re 
of 0.035) for all five planar locations analyzed contoured by the global in vivo velocity 
magnitude, while Figure 6.27 illustrates the exploded view of all six locations. 
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A B C 
D E 
Figure 6.25 - 2D in vivo velocity vector results for the five analyzed locations (A – E) corresponding to the 2nd 
through the 10th locations (see Figure 6.20A for locations) for Re = 0.035. 
A B 
Figure 6.26 - In vivo results for all five planar locations analyzed showing (A) contours and (B) vectors 
contoured by the global velocity magnitude for Re = 0.035.   (The maximum velocity that occurred in the 
planes analyzed was 0.21 mm/sec) 
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Finally, Figure 6.28 illustrates the top view of the emphy model which represents the in vivo 
magnitude and direction of the a-component of velocity for an in vivo Re of 0.035. 
 
 
 
A B 
Figure 6.27 - Exploded view of all five planar locations analyzed showing (A) contours and (B) vectors 
contoured by the in vivo global velocity magnitude for a Re = 0.035.  (The maximum velocity that occurred 
in the planes analyzed was 0.21 mm/sec) 
Figure 6.28 - Top view of the emphysemic human model representing 
the in vivo magnitude and direction of the z-component of velocity 
(for Re = 0.035). 
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6.5 – Comparison between Healthy and Emphysemic Models 
The flow fields for each model (healthy model normal and heavy breathing, and emphysema 
model normal breathing) were obtained experimentally under dynamically similar flow 
conditions.  Comparisons made under these conditions can only be qualitative.  For example, 
whether or not recirculation is present can be examined on the large scale.  However, the 
experimental results can be used to compare flow field magnitudes in vivo by scaling the 
experimental results back to in vivo size and breathing conditions.  The following sections 
analyze characteristics that affect the differences that exist between the two models. 
 
6.5.1 – Geometric Differences 
Table 6.5 represents the geometrical differences that exist between the healthy and emphysemic 
models (for both in vivo and experimental cases), while Figure 6.29 illustrates the physical 
differences existing between the prototypes used for experimentation.  A major difference 
existing between the two models is the presence of potential recirculation regions in the healthy 
model; occurring when the ductal flow is large compared to the alveolar flow (section 6.1.1).  
From observation, the healthy model had two such locations, but the emphysemic model did not 
contain geometry that would induce recirculation. 
 
Table 6.5 - Characteristics of in vivo and experimental healthy and emphysemic models. 
 
 
  
Duct 
Diameter 
(mm) 
Model 
Volume 
(mm^3) 
Overall 
Length 
(mm) 
Overall 
Width 
(mm) 
Scaling 
Factor 
In Vivo 
Model 
Healthy 0.41 1.3 1.7 2.1 N/A 
Emphy 0.9 14.4 3.5 3.9 N/A 
Experimental 
Model 
Healthy 8.0 9013.5 33 41 19.4 
Emphy 8.0 10488.6 31 35 8.9 
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The majority of the emphysemic model was merged into two large sections (Figure 6.29A); none 
of which contained regions 
where the alveolar mouth 
diameter was small compared to 
the alveolar depth.  The healthy 
model, however, contained 
multiple, well defined bulb 
structures with several distinct 
alveoli (Figure 6.29B). 
 
6.5.2 – Comparison of Flow Conditions 
Table 6.6 represents the comparisons between the in vivo and emphysemic breathing conditions 
and corresponding flow rates and velocities.  The effects of these differences are described in the 
following sections. 
 
Table 6.6 - Comparison between the healthy and emphysemic breathing conditions calculated for in vivo and 
experimental cases. 
  
Breathing 
Condition 
Time 
Averaged 
Re at 
Model 
Inlet 
Expansion 
(%) 
BF 
(breaths/min) 
Time 
Averaged 
Flow Rate at 
Model Inlet 
(mL/sec) 
U, Time and 
Spatially 
Averaged 
Velocity at 
Model Inlet 
(mm/sec) 
H
ea
lt
h
y
 In Vivo 
Normal 0.009 16 15.7 1.30E-04 0.97 
Heavy 0.035 60 15.7 4.91E-04 3.66 
Experiment 
Used in 
This Work 
0.138 35 15.0 1.94 38.60 
E
m
p
h
y
se
m
a In Vivo Normal 0.035 11 16.0 1.03E-03 1.61 
Experiment 
Used in 
This Work 
0.138 30 15.0 1.94 38.60 
A B 
Figure 6.29 - (A) Healthy and (B) emphysemic experimental prototypes.  
The circled portion represents the locations in the healthy model most 
likely to induce recirculation (6
th
 and 8
th
 locations). 
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6.5.3 – Normal Healthy Breathing vs. Normal Emphysemic Breathing 
The flow fields shown in section 6.1.1 conclude that reversible flow is present in the regions of 
potential recirculation (6
th
 and 8
th
 locations) and throughout the entire healthy human model.  
Reversible flow was also concluded for all regions in the emphysemic model.  Therefore, 
regardless of the magnitudes existing in the flow fields, both models exhibit characteristics of 
reversible flow.  This indicates that the fluid motion replicates the motion of the outer boundary; 
following the contours of the model as it changes shape.  In order to better understand the 
differences occurring between the two models, the in vivo normal healthy breathing (Re = 0.009) 
and normal emphysemic breathing (Re = 0.035) cases were compared.  It is seen in Table 6.6 
that the normal emphysemic in vivo flow rate at the model inlet is 8x larger than the flow rate 
seen in the normal healthy model (1.03E-3 mL/sec for normal emphysemic and 1.30E-4 mL/sec 
for normal healthy).  The average velocity occurring in the normal healthy model, however, is 
approximately 1.6x larger than the emphysemic model.  These differences stem from the flow 
conditions used for each in vivo model. 
 
The average flow rate is calculated based on the derivative of the volume change curve.  The 
change in volume for a given model is calculated based on the initial volume of the model and 
the desired percent expansion to occur over a known breathing period.  The average velocity is 
then calculated by dividing the average flow rate by the cross-sectional area of the inlet duct (a 
function of the duct diameter squared).  In vivo duct dimensions were used to calculate in vivo 
predictions (0.41 mm and 0.90 mm for healthy and emphysemic, respectively), while 8 mm was 
used for both experimental models.  Therefore, the larger initial volume of the emphysemic 
model (11x larger than healthy) coupled with the slightly smaller percent expansion (11% for 
emphysemic opposed to 16% for healthy; approximately 1.5x less) results in an average flow 
rate that is approximately 8x that seen in the heavy healthy model (11x larger volume / 1.5x less 
percent expansion).  The differences in average velocities are calculated based on the differences 
between in vivo duct diameters (0.90 mm for emphysemic and 0.41 mm for healthy). 
 
Figure 6.30 represents the predicted in vivo flow fields occurring close to the inlet of each model, 
when scaling to an in vivo Re = 0.009 for normal healthy breathing and Re = 0.035 for normal 
emphysemic breathing.  The difference between the maximum velocity magnitudes was 
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calculated to be 8% (2.34E-4 m/sec for normal healthy and 2.15E-4 m/sec for normal 
emphysema).  Even though the velocity magnitudes are similar, the distributions occurring 
throughout the each model vary significantly.  Figure 6.30A illustrates the flow entering the 
healthy model at a high velocity then uniformly slowing as the fluid moves towards the outer 
walls.  The emphysemic model (Figure 6.30B), however, yields a large region of fast flow near 
the inlet that begins to slow at non-uniform intervals. 
 
 
 
To further compare the differences existing in the normal healthy breathing and emphysemic 
conditions, the locations furthest from the inlet were analyzed representing the 2
nd
 location for 
both models (Figure 6.31).  The difference between the maximum velocity magnitudes at the 2
nd
 
location is approximately 66% (4.34E-5 m/sec for normal healthy and 8.57E-5 m/sec for normal 
emphysema).  The distribution occurring throughout the contours of the model vary between the 
different geometries at this location.  It is seen that the healthy model exhibits a very uniform 
flow field distribution with the magnitudes decreasing from the center of the model out towards 
the wall.  The emphysemic geometry, however, illustrates a non-uniform spread with the largest 
magnitude occurring close to the outer wall near the bottom of the model (furthest distance from 
the inlet of the model). 
 
A B 
Figure 6.30 - (A) 10th location in the normal healthy human model (Re = 0.009) and the (B) 8th location of the 
normal emphysemic model (Re = 0.035). 
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Based on the in vivo breathing conditions and initial model volumes, the normal emphysemic 
breathing model inhales 1.6 mm
3
 versus 0.2 mm
3
 for the normal healthy breathing model (a total 
of 8x more fluid).  This is an indication that particles traveling in the emphysemic model would 
travel deeper into the model than those in the healthy model by convection.  This result is 
interesting since the diffusion capacity of the lung decreases in emphysema (Park et al. 1970), so 
higher ventilation rates could be a way for the emphysemic lung to compensate.  However, 
particles are not able to deposit on the alveolar walls by this method of transport alone.  The 
overall size of the emphysemic model is significantly larger (11x) than the healthy model.  
Therefore, even though the initial traveling distance of a particle occurring in the emphysemic 
model may be longer due to convection, the outer bounds of the emphysemic model are much 
further away with respect to the finishing location of a particle.  Based on this final distance 
needed to travel by diffusion prior to depositing (distance from the end of a pathline to the 
nearest wall), it is concluded that particles would have a higher tendency to deposit in the healthy 
model rather than the emphysemic model because the walls are much closer to the ends of 
particle pathlines.  Residence time (the amount of time that a particle has to diffuse) plays little 
to no role in the overall diffusion occurring in each of these models because the in vivo breathing 
frequencies are similar (15.7 breaths/min for healthy and 16.0 breaths/min for emphysema).  If a 
significant difference were present (a frequency of 30 breaths/min for the healthy model, for 
A B 
Figure 6.31 - 2nd location in the (A) normal healthy human model (Re = 0.009) and the (B) normal 
emphysemic model (Re = 0.035). 
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example), particles might not have time to diffuse to the adjacent walls.  Similarly, if a longer 
breathing period were present for the emphysemic conditions, particles might have enough time 
to diffuse to the alveolar walls.  These conclusions agree with previous work completed by 
Jessica Oakes (2008) and Sturm and Hofmann (2004).  Both studies report decreased deposition 
occurring in emphysemic models with higher particle diffusion in the healthy models. 
 
6.5.4 – Normal Healthy Breathing vs. Heavy Healthy Breathing 
Figure 6.32 and Figure 6.33 illustrate the comparisons between the normal healthy and heavy 
healthy breathing in vivo predictions occurring at the 10
th
 location (closest to the model inlet) and 
2
nd
 location (furthest from the inlet), respectively.  It is seen that the heavy normal breathing 
models maximum velocity is 116% larger than the normal healthy magnitudes for both locations.  
This is due to 116% difference between the in vivo model expansions (16% for normal healthy 
and 60% for heavy healthy breathing), during the same time period. 
 
 
 
Because the heavy healthy model has an in vivo percent expansion of 60%, a total of 0.8 mm
3
 is 
inhaled each breath as compared to 0.2 mm
3
 for the normal healthy breathing condition (percent 
expansion of 16%).  This suggests that particles travel deeper into the heavy healthy breathing 
model by convection alone for a single breath.  Because each model has the same initial in vivo 
A B 
Figure 6.32 – 10th location for the (A) normal healthy human model (Re = 0.009) and the (B) heavy 
healthy model (Re = 0.035). 
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volume and breathing period, diffusion would also dominate in the heavy healthy model because 
the deeper particles would have less of a distance to travel to deposit on the alveolar walls.  
Similar to the normal healthy versus the normal emphysema case, residence time is irrelevant in 
this situation because the in vivo breathing frequencies are identical. 
 
 
 
6.5.5 – Heavy Healthy Breathing vs. Normal Emphysemic Breathing 
Although the breathing conditions for a healthy heavy breather are very different from an 
emphysematic breathing normally (shown in Table 6.6), the breathing conditions result in similar 
Re (Re = 0.035).  Even though the calculated in vivo Re are equal for heavy healthy and normal 
emphysemic breathing, the time averaged in vivo flow rates at the model inlets for the normal 
emphysemic breathing condition is 2x larger than the in vivo heavy healthy breathing (1.03E-3 
mL/sec for normal emphy and 4.91E-4 mL/sec for heavy healthy).  This is, again, due to the 
larger initial volume of the emphysemic model (11x larger than the healthy model), and the 
substantially larger percent expansion of the heavy healthy model (5.5x larger than the 
emphysemic expansion).  The difference between the two flow rates is found by the ratio of the 
volume differences to the expansion differences (11x larger emphysemic volume / 5.5x larger 
healthy expansion).  Similarly, the in vivo velocity at the model inlet for the heavy healthy case, 
however, is 2x larger than the normal emphysemic condition (3.7 mm/sec for heavy healthy and 
A B 
Figure 6.33 - 2nd location for the (A) normal healthy human model (Re = 0.009) and the (B) heavy healthy 
model (Re = 0.035). 
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1.6 mm/sec for normal emphysema).  These differences stem from the differences between the in 
vivo duct diameters (emphysemic in vivo diameter is 2x the healthy). 
 
The differences that exist between the in vivo flow fields were analyzed to compare the effects of 
the healthy and emphysemic geometries for similar non-dimensional flow fields (Re = 0.035).  
For example, Figure 6.34 represents the predicted in vivo flow fields that exist closest to the 
model inlet for both the heavy healthy (10
th
 location) and normal emphysemic (8
th
 location) 
models for an in vivo Re of 0.035 (refer to Figure 6.1 and Figure 6.20 for the laser plane 
locations for the healthy and emphysemic models, respectively).  The maximum in vivo heavy 
healthy breathing velocity magnitude is 8.86E-4 m/s, occurring near the inlet of the model, while 
the maximum normal emphysemic breathing in vivo magnitude is 2.69E-4 m/s; more than 3x less 
than the maximum heavy healthy magnitude with a difference of 107%. 
 
 
 
For further comparison, the 2
nd
 locations were compared to illustrate the differences existing at 
the furthest distances from the inlet of the model, again for an in vivo Re of 0.035 (Figure 6.35).  
The maximum velocity occurring at this location in the normal breathing emphysemic model is 
8.57E-5 m/s, representing a 63% difference from the heavy healthy model (1.64E-4 m/s). 
 
A B 
Figure 6.34 - (A) 10th location in the healthy heavy human model and the (B) 8th location of the normal 
emphysemic model (in vivo Re = 0.035). 
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Based on the in vivo breathing conditions and initial model volumes, the normal breathing 
emphysemic model inhales two times as much fluid as the heavy breathing healthy model (1.6 
mm
3
 versus 0.8 mm
3
, respectively).  Similar to the conclusions made in section 6.5.3, the 
difference in volume change indicates that particles would travel deeper into the emphysemic 
model by means of convection.  The larger volume change of the heavy breathing healthy model 
(as compared to the normal breathing healthy), however, indicates that particles would travel 
deeper into the heavy healthy breathing as compared to the normal breathing healthy.  Therefore, 
the travel distance required for deposition in the heavy healthy model is significantly less than 
previously seen in the normal healthy model.  This suggests that particles in the heavy healthy 
model would diffuse at a much faster rate than in the emphysemic model even if the emphysemic 
volume is 11x larger than the healthy model.  Residence time continues to have little effect in 
this case because the in vivo breathing frequencies are similar. 
A B 
Figure 6.35 – 2nd location in the (A) heavy healthy human model and the (B) normal emphysemic model 
(in vivo Re = 0.035). 
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Chapter 7: Conclusions and Discussion 
 
7.1 – Remarks 
The present research was successful in the execution of its predefined goals (Chapter 1): 
1. Create compliant hollow models 
 Two experimental model prototypes were created from in vivo healthy and 
emphysemic human lung geometries.  The healthy model was 19.4x in vivo size, 
while the emphysemic model represented 8.9x in vivo dimensions.  Compliant 
models were then obtained for both experimental geometries using the dipping 
techniques developed in our lab. 
 
2. Develop PIV setup capable of 3D flow field analysis 
 Stereoscopic particle image velocimetry (stereoPIV) techniques were successfully 
employed to visualize the 3D fluid flows occurring in each of the experimental 
models.  An experimental setup was developed to accommodate the necessary 
components in the system while a LabVIEW program was created to expand and 
contract the compliant models based on the desired input parameters.  A fluid 
scaling analysis was performed to ensure that the in vivo flow fields were well 
represented experimentally.  Finally, the stereoPIV setup was validated by 
comparing the results of a full experimental analysis of simple 3D bulb geometry 
to the results of a CFD analysis. 
 
3. Complete stereoPIV analysis on healthy and emphysematous models 
 Using the validated setup, healthy and emphysemic models were analyzed and 
compared.  Specifically, the differences in model geometries were compared 
along with the variations that occur in each of the flow fields (i.e. velocity 
magnitudes and velocity distributions across a given plane).  Finally, the 
characteristics that affect particle transport were discussed and compared between 
the healthy and emphysemic models. 
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7.2 – Healthy versus Emphysemic Models 
It was shown that major geometric differences exist between the healthy and emphysemic 
geometries.  The major difference separating the two models is the presence of potential 
recirculation regions in the healthy model.  These locations were determined based on defined 
bulb structures that yield small ratios of alveolar depth to mouth diameter.  The emphysemic 
model, however, contained no such geometry.  In fact, the overall appearance of the emphysemic 
model appeared to contain two distinct sections merged into a single large alveolus.  The 
predicted in vivo flow fields yield reversible flow occurring everywhere in each model.  
Therefore, the geometric differences had no impact on the presence of reversible or recirculating 
flow. 
 
The velocities occurring closest to the model inlet in the typical emphysemic breathing model 
were larger than those found in the typical healthy breathing flow fields.  Therefore, more 
ventilation occurred in the typical breathing emphysemic model (as compared to the typical 
breathing healthy model) because of the higher average flow rates at the model inlet.  The 
healthy model exhibited a very uniform flow field distribution with the magnitudes decreasing 
from the center of the model out towards the wall.  The emphysemic model, however, illustrated 
a non-uniform spread.  It was concluded that particles are more likely to deposit in the normal 
healthy breathing model rather than in the normal breathing emphysemic model because of the 
ratio of percent expansion to initial model volume.  Even though particles would potentially 
travel deeper into the emphysemic model, the distance required to deposit would be less for the 
healthy normal breathing condition.  These results agree with the previous studies of Oakes 
(2010; 2008) and Sturm and Hofmann (2004) who studied the differences occurring between 
normal healthy breathing and normal emphysemic breathing. 
 
Because of the larger model percent expansion, the velocities occurring throughout the heavy 
breathing healthy model were significantly larger than those seen in the normal breathing healthy 
case (for all locations analyzed).  In addition, because particles travel further into the heavy 
breathing model, they have a higher tendency to deposit on the alveolar walls. 
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The same flow field distributions occurred between the heavy breathing healthy and normal 
breathing emphysemic comparison as was shown between the normal breathing healthy and 
normal emphysemic breathing case.  Because of the larger inlet flow rates, however, more 
ventilation was seen in the normal breathing emphysemic case.  Finally, it was concluded that 
particles would be more likely to deposit in the heavy breathing healthy model as opposed to the 
normal emphysemic model because of the larger percent expansion, and, therefore, expected 
deeper penetration of the healthy breathing heavy model. 
 
7.2.1 – Discussion of In Vivo Predictions 
As shown in Chapter 2, the size and location of the inlet ducts for each model were arbitrarily 
chosen to fit with the contours of the model.  The below discussion aims to address how the 
dimensions and locations of the inlet ducts and the final chosen models affects the in vivo 
predictions as defined in section 6.5. 
 
7.2.1.1 – Residence Time 
Residence time is defined as the amount of time a particle has to deposit in the lung during a 
single breath.  It is determined based on in vivo conditions from literature; specifically breathing 
frequency.  The predicted residence times in this work are relevant to in vivo conditions because 
the in vivo flow parameters were matched between the in vivo and experimental models; 
assuming that the breathing frequency used for the entire lung is the same that occurs in 
individual alveoli.  Because residence time is related to the breathing frequency, the sizes of the 
final model section and the duct diameter have no effect on particle residence time.  The 
residence time for emphysemic conditions is slightly lower than those seen in typical healthy 
humans because the in vivo breathing period is smaller (3.7 seconds for typical emphysemic 
conditions and 3.8 seconds for typical healthy conditions).  Therefore, particles will have a 
longer time to deposit in the healthy model as opposed to the emphysemic model.  In this work, 
the difference between typical healthy breathing and heavy healthy breathing is percent 
expansion.  Therefore, the residence times in these models are equal. 
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7.2.1.2 – Particle Penetration Depth 
Penetration depth is the distance a particle (either air or aerosol) is expected to travel into the 
lung for a given breathing period, as measured by the distance from the position at the start of 
inhalation.  In our model, we predicted measurements from the duct entrance, which would 
represent a particle that was already in the lung at the alveoli at the start of inhalation.  
Penetration depth cannot be determined directly from the presented results since three-
dimensional pathlines are required.  However, the 3D flow fields can be used in the future to 
derive this information.  For this work, we estimated relative penetration depth to inhalation 
volume.  The functional residual capacity (FRC) and tidal volume (inhaled volume) were taken 
from literature and the expansion was calculated by the tidal volume / FRC.  It should be noted 
that penetration depth must be related to the location of the final position of a particle relative to 
the model wall, since the wall is where gas exchange and particle deposition occurs.  If we 
assume that the lung expands uniformly in every lobe and alveoli, the percent expansion of the 
model is directly related to in vivo expansions.  Although absolute volume inhaled is directly 
related to the size of the initial model selected, the desired percent expansion is not affected by 
model or duct size.  Therefore, relative penetration depth is not affected by the size of the model 
or the duct diameter; it is related to the applied model expansion.  In this work, we made 
observations about the penetration depth relative to the inhaled volume (the percent of inhaled 
volume relative to the total volume of the model).  This comparison was completed for each of 
the three cases (typical healthy versus typical emphysemic breathing, typical healthy versus 
heavy healthy breathing, and heavy healthy versus typical emphysemic breathing) and is 
presented in the above section (section 7.2).  In conclusion, even though the penetration depth is 
higher in the emphysemic model as compared to the typical healthy model, the relative 
penetration depth is smaller because the volume required to penetrate is much larger in the 
emphysemic as compared to the healthy model; for the models chosen in this work. 
 
If a different model were created with a larger duct diameter, for example, the model volume 
would be less due to a smaller required scaling factor to obtain in vivo dimensions.  If the same 
input parameters were applied to this new model, specifically percent expansion, the relative 
penetration depths would be identical.  Therefore, the penetration depth predictions presented 
above are very relevant to in vivo. 
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7.2.1.3 – Particle Deposition 
Deposition by diffusion and sedimentation depends on both penetration depth and residence 
time.  Penetration depth defines how far a particle is carried in from the convective motion of the 
wall expansion and how much distance is remaining to get to the wall after inhalation.  
Residence time is how long particles are in the lung or the time allowed for particles to deposit.  
Because the breathing periods are similar for healthy and emphysemic conditions, the residence 
times are analogous.  As described above, the penetration depths in typical emphysemic models 
are larger than those seen in typical healthy models because of the model percent expansion.  
The volume to penetrate in the typical emphysemic model, however, is much larger than the 
typical healthy model, which yields lower deposition by diffusion in the typical emphysemic 
model as compared to the typical healthy model.  Because the heavy healthy model has a larger 
percent expansion, however, deposition is even more prevalent in the heavy healthy model as 
compared to the typical emphysemic model.  Similarly, deposition is greater in the heavy healthy 
model as compared to the typical healthy model because of the large difference in percent 
expansion.  Note that we are assuming a lumped capacitance approach to these predictions.  This 
assumes that diffusion from the streamline occurs only after a particle is completely inhaled.  In 
reality, however, drifting from the streamline occurs during inhalation. 
 
7.2.1.4 – Flow Rate 
The input flow rates applied to each model were determined based on the initial model volume, 
breathing period, and desired percent expansion.  If different model dimensions were used, 
however, the flow rates would be affected by the initial model volume of the model.  From 
Chapter 2, the model size is determined based on the scaling factor applied in order to achieve 
the appropriate duct diameter.  Therefore, if the duct diameter’s arbitrary dimension were 
increased, for example, the scaling factor would be decreased, therefore decreasing the initial 
volume of the model (assuming the same model location was selected from the original cast).  
Assuming the same input breathing period and percent expansion, a lower input flow rate would 
result in a model with a larger in vivo duct diameter as opposed to the models used in this work. 
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7.2.1.5 – Velocity Fields 
The experimental velocity fields determined from stereoPIV were scaled back to represent in 
vivo flow fields using in vivo flow conditions (see Chapter 3).  These in vivo fields allowed us to 
demonstrate the importance of diffusive relative to convective motion, which is needed to model 
air and particle flow.  Similar to the flow rates, the velocity field magnitudes would change if 
different models were created other than the ones used in this work.  Again, for example, if a 
larger arbitrary duct diameter was chosen, the resulting model volume would be smaller than that 
seen in this work.  This would yield smaller experimental velocity magnitudes.  The resulting in 
vivo flow fields would also have smaller magnitudes because the ratio of the experimental 
diameter to the in vivo diameter would be less than that used in this work. 
 
7.3 – Limitations of Work 
One limitation in the current research is the settings of the cameras used to acquire raw PIV 
images.  The most accurate setting would be 90° between the cameras, but because of restricted 
optical access, smaller angles were required, reducing the accuracy of the results, particularly in 
the z-direction as shown in the bulb model.  Therefore, to optimize the vector field results, 
Scheimpflug mounts are traditionally used.  In this work, however, Scheimpflug mounts were 
not used.  If future work is performed, the use of these mounts is highly recommended to 
optimize the accuracy of the experiments (especially the z-component of velocity). 
 
Another limitation of the experimental setup involved the location of the syringe pump used to 
expand and contract the experimental models.  Because the pump was located to one side of the 
model, the rig had a tendency to non-uniformly expand the compliant models during 
experimentation, and was illustrated in the boiling flask validation.  This non-uniform expansion 
resulted in the velocities on the left side of the model being less than the predicted values with 
the right side velocities being higher than the predictions. 
 
A final limitation existing in the experimental setup dealt with the tracer particles.  Over long 
periods of time, the particles had a tendency to disperse unevenly throughout the model.  
Unfortunately, the only way to re-mix the particles required the entire model to be removed from 
the setup.  Because of this movement in particles, experiments for a given model needed to be 
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completed in a single setting as to not detect the rising of the particles.  This limitation, however, 
had no affect on the results of this study. 
 
7.4 – Future Work 
The conclusions generated from the in vivo predictions related to particle transport occurring in 
healthy and emphysemic geometries.  Quantitative results for particle penetration depths were 
unable to be calculated in this work because it was unclear how potential particles would travel 
in a non-symmetric model.  Pathlines were also unable to be calculated because time elapsed 
sequences were not analyzed.  It is suggested for future work, however, to extract 3D pathlines to 
determine the penetration depths and general paths of particles throughout healthy and 
emphysematous models.  3D pathlines would also allow for more accurate predictions of 
convective transport. 
 
As stated above, the accuracy of the experimental results was reduced because the Scheimpflug 
mounts were not used in the experimental setup.  If future stereoPIV work is completed, the use 
of these mounts is highly recommended to maximize the accuracy of the desired outputs.  These 
mounts would also increase the quality of the raw images because the entire field of view would 
be in focus; optimizing the correlation peaks in the image processing. 
 
It was demonstrated that a measured conversion factor is desired to compare to the factor 
calculated by Insight.  Although this was done for the boiling flask model, it was not completed 
for the emphysemic or healthy models.  Therefore, the results of the healthy and emphysemic 
models contain a small amount of error from the pixel to length conversions (as calculated in 
Insight 3G).  It is suggested to measure the conversion factors for the laser plane locations used 
in the reported results and scale the experimental and predicted in vivo velocity fields by the ratio 
of the measured to the calculated conversion factors.  Finally, compare the differences between 
the results from the two geometries when using the calculated factor versus the measured factor. 
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